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Abstract
Radiation therapy planning systems utilize CT imaging to determine the electron
density of patient anatomy and measurement phantoms. The properties of the
kilovoltage photons from a CT scanner are different to the megavoltage photons used
for treatment on a linear accelerator, meaning that a CT Number to electron density
calibration is required. However not all materials have the same CT Number to
electron density conversion as it is a complicated relationship, depending on the
atomic number, physical density and electron density of the material.

The aim of this work was to develop a technique to identify such materials using the
megavoltage X-ray of a linear accelerator and electronic portal imaging device
(EPID). The technique uses the pixel values of a single planar image to identify an
unknown material that is contained within a known substance, such as a metal
prosthesis within tissue. Another use is the accurate determination of the electron
density of a phantom material for use in dosimetry measurements. Simple,
homogeneous phantoms were measured to within 3 % of their reported electron
density. The identification of an inner portion of a multi-part phantom was also
successful, with reported values matching the measured results within experimental
uncertainty.
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Chapter 1: Introduction

1. Introduction
1.1

Overview of Radiation Physics

Radiation is a broad term that can be used to describe any part of the electromagnetic
spectrum, be it radio waves, visible light or X-rays, as well as the emission of
particles such as alpha, beta and protons. In general usage the word describes the
potentially harmful high-energy radiation that has the ability to ionise regular matter.
On a cellular level, exposure to ionising radiation has the potential to prohibit or alter
cell function via the breakage of chemical bonds. This chapter will provide a brief
introduction to the types of radiation to be discussed in this work, the manner in
which they acquire and deposit energy and how this is quantified for use in the
context of radiation oncology medical physics. It will focus on an entry level
understanding of radiation oncology physics and the associated terminology pertinent
to this project.

1.1.1

Interactions of Ionising Radiation

Ionising radiation can be divided into two distinct groups – directly ionising and
indirectly ionising radiation. Directly ionising radiation includes charged particles
such as protons and electrons or less commonly alpha particles and other heavy ions.
With enough kinetic energy, the collision of these particles with an orbital electron
can cause the ejection of the electron and the atom becomes positively charged, or
ionised. Conversely, a neutral atom may trap an incident electron, causing it to
become negatively charged. Charged particles can also react with the nucleus, where
the influence of the Coulomb force can slow the particles and cause bremsstrahlung, a
German word for ‘braking radiation’ describing the conversion of kinetic energy to
photons. This process is used for photon production in medical linear accelerators.
Indirectly ionising radiation comprises uncharged neutrons and photons, which do not
directly cause ionisation, but impart energy to electrons and atoms within a medium
which then act as directly ionising particles themselves. Photons, specifically the high
energy X-rays or Gamma rays, are the most commonly used modality in radiation
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therapy and interact in three main processes: the photoelectric effect, Compton
scattering and pair production.
The photoelectric effect occurs when a photon is absorbed by an atom which then
ejects an electron with energy, Ee, equal to that of the incident photon, hv, less the
binding energy of the electron, Eb.
E e = hv − Eb
The ejected electron leaves a vacancy in the atom, which if filled with an electron
from a higher shell can also produce a characteristic X-ray. The photoelectric effect is
the primary interaction for cases of low energy and a medium of high atomic number.
Compton scattering is the dominant interaction for megavoltage photon beams used in
radiation therapy. In this process, the incident photon collides with an electron with
negligible binding energy in comparison to the photon energy. The photon imparts a
portion of its energy to the electron and is scattered by an angle related to its change
in energy by the equation
hv

hv' =
1+

hv
(1 − cos θ )
m0 c 2

where a photon of energy hv is scattered by an angle θ and decreases in energy
to hv’. The rest energy of an electron, m0c2 is equal to 0.511 MeV. For a Compton
scatter scenario the electrons in the medium can be considered a sea of free electrons
rather than bound to atoms, so these interactions are independent of atomic number
and the likelihood of an interaction occurring is based on the electron density of the
absorbing material.
At energies over 1.022 MeV (twice the electron rest energy) the possibility of pair
production comes into effect. In this situation the incident photon reacts with the
electromagnetic field of the nucleus and converts all of its energy to form an electronpositron pair, with the excess energy above 1.022 MeV conserved as kinetic energy of
the particles. As the size of the nucleus grows, the probability of the photon
interacting with the coulomb field increases, therefore the potential for pair
production rises as atomic number increases.
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1.1.2

Measurement and Quantification of Radiation

Many terms exist that characterise both the type of radiation in use and the material
through which it passes. In a radiation therapy treatment this material is the patient’s
body, and each patient presents unique internal and external anatomy that must be
accounted for in order to achieve maximum accuracy. The human body is a complex
mixture of tissue types which must be considered when planning a treatment, as the
electron density is different in each case. In general practice, however, most of the
body can be thought of as water-equivalent, and thus when speaking of radiation
characteristics and depths of absorption one usually does so with reference to a water
absorber, although this is not always explicitly stated.
The most general description of a therapeutic photon beam is its nominal energy,
which is given as the accelerating potential in megavolts needed to generate the
equivalent photon spectrum in an X-ray tube. Medical linear accelerators instead use
an accelerating waveguide to accelerate electrons to relativistic speeds for
bremsstrahlung production and are capable of generating multiple beam energies,
typically a 6 MV beam and one or two higher energies such as 10 MV and 18 MV.
To properly quantify a radiation beam there must exist easily measurable parameters
that can be used to compare and verify the output of a machine, including
characteristics in the direction of the beam axis at various depths or distances from the
source, and perpendicular to the beam axis at points between the centre of the beam to
beyond the defined field edge. Some measurements that can be made to ensure the
consistency of the beam are:
dmax – the depth at which maximum dose occurs – around 15 mm in water for
a 6 MV beam and 22 mm for a 10 MV. This is usually obtained by
scanning a detector along the central axis of the beam, acquiring a dose
reading at a range of incremental depth positions (Figure 1.1). This
should not be confused with the common notation for maximum dose,
Dmax.
Symmetry – describes how symmetrical the radiation field is in each direction
away from the central axis. The symmetry should be as close to perfect
as can be achieved. There are several common ways to make
measurements of beam symmetry, including the use of a detector array,
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Figure 1.1 A depth dose curve for a 6 MV photon beam, showing maximum dose at a
depth of 15 mm.

scanning a single detector perpendicular to the beam axis and recording a
dose reading at a range of incremental points, or exposing and analysing
a piece of film. These detectors are most commonly placed at a depth of
dmax, where variations are most easily observed. An example of a
mathematical expression for symmetry is 100×Max(|L/R|,|R/L|), where L
and R are readings at equal distance either side of the central axis, within
a region deemed to be the in-field area (IEC, 1989).
Flatness – indicates the magnitude of difference between the highest and
lowest dose within the field. Due to machine design, to be discussed
later, the flatness can be optimised at only one depth, and thus the shape
of the beam profile changes with depth. The flatness can be obtained
from the same measurements used for symmetry. An example of a
mathematical expression for flatness is 100×Dmax/Dmin, where Dmax and
Dmin are the maximum and minimum readings anywhere in the region
deemed to be the in-field area (IEC, 1989).
TPR – the Tissue Phantom Ratio, in general, describes the ratio of the dose to
a fixed point at a required depth to the dose to the same point at a
reference depth. An example is the TPR20/10 - the ratio of dose at a fixed
point at 20 cm depth to the same point at a reference depth of 10 cm.
(Figure 1.2). A continuous TPR can be acquired with tank systems that
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allow programmed water surface control, otherwise a specific ratio such
as the TPR20/10 can be measured manually with two static readings at the
required depths.

Figure 1.2 TPR20/10 is the ratio of the dose at the measurement point with 20 cm depth to
that with 10 cm depth.

As well as describing the properties of the radiation, there is a need for terms that
describe the characteristics of the material through which the radiation passes. This
may be a patient or a substitute material for testing and quality assurance known as a
phantom. As the ability to conduct in vivo dose measurements is extremely limited,
phantoms are essential for the measurement of dose values and distributions. The term
‘phantom’ can be used to describe anything from a simple block of tissue-equivalent
material to a heterogeneous anthropomorphic model used in more complex studies
(figure 1.3). In most clinical departments, a product such as Plastic WaterTM
(Computerized Imaging Reference Systems Inc, Norfolk, USA) or Solid WaterTM
(Gammex Inc, Middleton, USA) is used for patient dose verification studies as well as
quality assurance of machines and research projects.
Available in thicknesses from 1 mm to several centimetres, these products allow for
the prompt setup and adjustment of a radiation detector at a required depth, and
provide a much easier and more efficient method than conducting real water tank
measurements, which are generally reserved for infrequent tasks requiring maximum
accuracy. The drawback of these substitutes is that while they can be designed to
replicate the dosimetric properties of water in a certain energy range, the response in
different ranges may not be as accurate.
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Figure 1.3 (Top) Plastic Water pieces, one with a suitable cavity to place a detector.
(Bottom) Anthropomorphic phantom with authentic organ properties

There are many physical attributes of a material that can be considered, however if
every physical quality of water was used in producing a material, the end product
would be, inevitably, water. Thus the design of a substitute that mimics water while
providing solidity, durability and cost effectiveness can focus only on the main
characteristics that influence radiation in the desired energy range. Some of these
considerations are:
Mass density – the physical mass per unit volume, ρ (gcm-3), of the medium.
Electron density – the number of electrons per unit volume in the material,
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sometimes designated ρe. Commonly stated as the relative electron
density (RED) with respect to that of water.
Effective Atomic Number – used to describe a compound substance as if it
were a single element. Also known as the weighted mean atomic
number, the number is calculated using the atomic number of each
component and the number of electrons contributed from that nucleus as
a fraction of the whole. The Mayneord (1937) formula is commonly
adopted with the value for water and regular tissue around 7.

These terms are consistent physical characteristics of a given material as they describe
only the structure of the medium, however when the behaviour of radiation in that
medium is to be described it is not so simple. The same media will react differently to
radiation of different types and energies, therefore terms are required that describe the
behaviour of a specific type and energy of radiation in a particular material.
Attenuation Coefficient – the factor, designated µ, which describes the
exponential attenuation through a medium. Under narrow beam
geometry, photons are attenuated according to the expression

I ( x) = I 0e − µx
where the original intensity, I0, decreases to I(x) after passing through a
distance x (cm) of material with attenuation coefficient µ (cm-1). It is
important to recall that while attenuation coefficient can be thought of as
a property of a material, it depends also on the photon energy.
Mass Attenuation Coefficient – as the attenuation coefficient of absorber is
influenced heavily by its density, ρ (gcm-3), it is often convenient to
compare materials in a way that is independent of density. This is done
using µ/ρ (cm2g-1), so that comparisons show only the difference due to
the atomic make-up of the material. When µ/ρ is used in place of µ, units
of x must be multiplied by ρ to compensate leading to the unit of length
gcm-2, which is used commonly in calculations of attenuation.
Half Value Layer – the thickness of absorber required to attenuate a beam of
photons to half its original intensity.
Energy absorption coefficient – importantly, this quantity µen (cm-1) describes
the amount of energy absorbed in the material which gives an indication
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of actual radiobiological effects. It is calculated by multiplying the
attenuation coefficient by the fraction of energy converted into kinetic
energy of charged particles, and then by the fraction of this kinetic
energy absorbed into the material (not lost as bremsstrahlung).
Mathematically,

µ en =

E
µ (1 − g )
hv

where E is the average energy converted to kinetic energy of charged
particles (MeV), hv is the photon energy (MeV), and g is the fraction of
E converted to bremsstrahlung.
Stopping Power – for charged particles, the stopping power, S (MeVcm-1),
describes the rate of energy loss across an absorber, dE/dx.
Linear Energy Transfer (LET) – defined in ICRU Report 16 (1970) as ‘the
quotient dE/dl, where dE is the average energy locally imparted to the
medium by a charged particle of specified energy in traversing a distance
of dl.’ LET can be used to describe both directly and indirectly ionising
radiation, with the commonly used X-rays and electrons of therapeutic
energy considered low LET (<10 keV/µm) and protons, high energy
neutrons and heavy charged particles are high LET.

Finally, a method of quantifying radiation dose is required for prescribing and
recording purposes. In radiation therapy, the dose to a patient is reported in the units
of gray (Gy ≡ 1 J/kg), which represents the energy absorbed per unit mass. The more
commonly known sievert (Sv) is also equivalent to J/kg, however this unit is used for
macroscopic dose quantification quantities such as equivalent dose, the dose to an
organ multiplied by a radiation weighting factor, and effective dose, the equivalent
dose multiplied by a tissue weighting factor. Radiation and tissue weighting factors
are used to account for the relative biological effect of different types of radiation and
tissue type sensitivity, respectively. The gray is a purely physical unit and relating the
biological outcome of delivering a certain number of gray to a particular region of the
body relies upon the experience of and data available to the radiation oncologist.
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Using a combination of these terms allows for the description and/or comparison of
different types of radiation and matter such that one can use a beam of radiation to
accurately deliver a desired dose distribution.

1.2

Introduction to Radiation Therapy

1.2.1

The Basis of Radiation Therapy

To anyone that has remained unprotected in the sun for too long the effect of radiation
on living cells is obvious, however, the X-rays generated by a linear accelerator are
far more energetic than the UV rays from the sun, which are just outside the visible
range of the electromagnetic spectrum. Consequently, the high energy therapeutic
photons are able to penetrate deeper into tissue and undergo interactions which can be
used to treat malignant disease.
Radiation causes cell death due to the damage caused by interaction of high energy
particles with cellular structures including the DNA, breaking chemical bonds and
altering the chemical composition that dictates normal cell function. Depending on the
LET of the radiation this may occur either directly, such as ionisation of a critical
structure, or indirectly via the production of highly reactive free radicals which cause
chemical changes resulting in biological damage. Damage to DNA must be very
concentrated to cause irreparable destruction. Single strand breaks can usually be
repaired, but localised double strand breaks cause mostly irreversible damage. When a
double strand break within the same rung of the DNA helix occurs, complete
chromosome breakage results. While the dense energy deposition caused by high LET
modalities is advantageous in this regard, radiotherapy commonly utilises low LET
photons and electrons, for which indirect interaction accounts for the majority of
damage and results from free radical production within the cell. As the cell is
predominantly water, the free radicals are mainly hydrogen-oxygen molecules, and
thus the oxygen supply to a cell plays an important role in its sensitivity to radiation.
The radiosensitivity of the cell also varies according to the age of the cell in the
reproductive cycle. Cells are generally most radiosensitive in the G2 (after DNA
synthesis) and M (mitosis) phases, and radioresistant in the S (DNA synthesis) phase.
Following irradiation, cell destruction may occur in any number of ways, including
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fatal structural damage to the cell membrane, failure to reproduce, and improper
reproduction resulting in the prevention of further proliferation.

Conveniently, there are several factors that allow biological damage to be biased
toward a tumour and the dose to healthy tissue kept to a minimum. Firstly, there is the
effect known as the therapeutic window, which describes the difference in response
between tumour and normal tissue. In a dose-response graph such as illustrated in
figure 1.4, two sigmoid lines represent the tumour control probability (TCP) and
normal tissue complication probability (NTCP). Each increases with increasing dose,
however the TCP has a lower threshold allowing for a window in which the optimum
dose can be delivered to give high probability of tumour control and small likelihood
of normal tissue morbidity.

Figure 1.4 A simplified dose response graph demonstrating the therapeutic window. An
optimum dose, as indicated by the dashed line, can offer a relatively high probability of
tumour control while minimising the risk to healthy tissue.

While figure 1.4 shows a somewhat optimal condition, the size of the window will
vary according to the specific tissues involved, as will the gradient of the curves,
making the choice of dose to deliver less obvious. It should also be noted that due to
the nature of malignant disease and metastatic spread the TCP will never reach unity,
i.e. a large dose can never be certain of controlling the tumour.
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Fractionation of treatments is another technique used to improve the outcomes of
radiation therapy. Rather than deliver the prescribed dose in one sitting, it is split into
a number of shorter treatments and delivered over a longer period. Depending on the
prescribed dose and aim of therapy, treatments are typically split into 20-30 fractions
and patients will receive one treatment every week day until all fractions have been
delivered. The effect of fractionation can be described by what became known as the
Four R’s of Radiobiology (Withers, 1975):
Repair – the ability of healthy cells to recover from sublethal radiation damage
during the time between fractions;
Redistribution – the temporal movement of cells through different stages of
the cell cycle that have varying sensitivity to radiation.
Repopulation – the proliferation of surviving cells between each fraction
Reoxygenation – as discussed above, the oxygen supply is important to
biological effect, thus tumour cells that have survived due to poor
oxygen supply (furthest from capillaries) can potentially become more
sensitive to radiation if the oxygen supply improves for the next fraction.

A fifth ‘R’, radiosensitivity, was introduced by Steel et al (1989) to describe the
observed difference in inherent response between different types of tumour.
Depending on the tumour type, then, the fractionation regimen may be adjusted for
the radiosensitivity of the tumour or radiation therapy could be ruled out altogether.

1.2.2

Use of External Photon Beams

Despite the aforementioned concepts allowing for tumours to be targeted
preferentially, the effective sparing of normal tissue is not significant enough to allow
the delivery of high doses of radiation without consequence. For this reason, modern
linear accelerators are capable of delivering fields of custom shapes and sizes from
almost any direction around the patient. For reasons of time effectiveness, setup
accuracy and ease of planning, the beams are usually arranged radially around a
patient that lies supine on a treatment couch.

As a megavoltage photon beam penetrates matter, the resultant dose as a function of
depth can be shown in a depth-dose curve. These are usually shown with dose as a
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percentage of the maximum dose, Dmax, and referred to as a percent depth-dose curve,
or PDD. The photon PDD is characterised by a small surface dose, steep build up in
the region between the surface and Dmax before a long gradual drop off in dose. The
maximum dose, Dmax (Gy or %), is not to be confused with the depth at which
maximum dose occurs, the lowercase dmax (cm).

Figure 1.5 An example of PDDs measured in a water tank, with a 6 MV beam (red), 10
MV beam (orange) and 15 MV beam (yellow) all individually normalised to 100 % at Dmax.
The higher energy beam can be seen to deliver maximum dose at increased depth and have
a shallower dose drop-off.

Photons are indirectly ionising, releasing energy via excitation of electrons which
travel a distance (predominantly) downstream as they deposit energy. At the surface
of the medium, there are few electrons upstream to be scattered down to this point, so
little dose occurs from backscatter and the ‘contaminant’ electrons released from the
head of the linac and in the air in front of the surface. With increasing depth, the
amount of material (and therefore electrons) upstream increases, so dose builds up
until the distance from the surface exceeds the penetrating range of the electrons and
an equilibrium is reached at which point the dose decreases with depth due to the
attenuation of the beam and inverse square relation of the photon fluence. With
increasing photon energy, the angular spread of interaction becomes more forward
directed and the range of secondary particles increases, therefore dmax increases with
energy.
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If more than one field is used at different angles around the patient such that they
converge on the tumour, this allows the required dose to be delivered to the tumour
with significant sparing of surrounding healthy tissue, as the unwanted dose to healthy
tissue is spread around the body instead of being concentrated along one path. Threedimensional Conformal Radiation Therapy (3D-CRT) implements several fields of
different shapes so that the intersection of beams conforms to the tumour volume. The
point at which the treatment head rotates is known as the isocentre. In the context of
the treatment room, the isocentre is a fixed physical point in space, however in terms
of the patient coordinate system the isocentre can be moved to anywhere in the body
in order to achieve suitable beam geometry. Of course, in reality, it is actually the
patient that is moving relative to the isocentre by setting up the treatment couch to the
desired location.

Figure 1.6 The arrangement of beams around a patient is usually in a coplanar fashion – the
patient ordinarily lies supine on the couch as the treatment head moves axially around them,
delivering beams radially toward the isocentre.

The machines generally have a distance of 100 cm between the isocentre and the
radiation source, and this parameter is known as the Source-to-Axis Distance (SAD).
The distance of a point from the source is significant as, similarly to any beam of
light, the radiation field diverges according to the inverse square law as it gets further
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from the source. Consequently the physical size of a field gets larger as distance from
the source increases, and so when references to field or jaw dimensions are made,
these refer to the size at the isocentre unless otherwise stated.

Another common parameter in radiation therapy is the Source-to-Surface Distance
(SSD). The SSD refers to the distance between the source and the patient, or, for
physics measurements, the surface of the phantom being used. The SSD can be
specified along the ‘ray-line’ between the radiation source and any point at depth in
the patient or phantom. In treatment planning, the SSD to a particular point is simply
a by-product of the location of the point and the depth of the point along the ray-line
connecting the source and point (figure 1.7a). For physics measurements, reference to
SSD is usually just a description of the distance of the phantom surface from the
source along the central axis of the beam (figure 1.7b).

Figure 1.7 a) For patient treatment planning, the SSD for a particular reference point (two
examples shown) is the distance of the point from the source less the depth of the point
along the ray-line. b) In measurements where SSD is listed as a setup parameter, it simply
refers to the distance of the surface from the source along the central ray-line.

Until this point, discussion of treatment beams has focussed mainly on the central
axis of the beam. It has been seen in the PDD graphs that the dose decreases with
depth as attenuation of the beam occurs. The relative dose across a field perpendicular
to the angle of incidence is ideally flat, however due to mechanical and physical
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constraints it cannot be perfect. Consequently, the dose varies across the field slightly
as well, and this is displayed in field profiles in figure 1.8.

Figure 1.8 Beam profiles at 1.5 cm (red), 5 cm (orange), 10 cm (yellow) and 20 cm depth
(green) for a 30 cm wide 6 MV beam at 90 cm SSD. The dose axis has not been
normalised.

As shown in figure 1.8, the variance in intensity across the profile is not the same for
all depths, and many notable differences can be made in comparing the two scans. In
order to produce a near uniform intensity across the field, a cone-shaped flattening
filter is used to attenuate the more intense central part of the raw photon flux such that
the resulting profile is flat, however this can only be optimised at one depth. Due to
the attenuating power of the flattening filter, the average energy in the centre of the
beam, where it must pass through a thick section, is higher than that toward the edge,
where relatively lower energies can pass through the thin part of the filter. As a result,
the beam is ‘softer’ at the edges, and therefore is more obviously affected by
attenuation, so for depths above that at which the flatness is calibrated, the intensity is
higher at the edges of the beam, giving rise to the so-named ‘horns’ on either side of
the beam. Conversely, at depths beyond that of calibration, the relative response falls
off to give a more rounded shoulder to the profile.
Additionally, the profiles shown display evidence of the divergence of the field, with
the width of the profile increasing with depth (and therefore distance from the
source). As no normalisation has been performed, the scans also show the decrease in
dose as depth increases.

In order to deliver the correct dose to the patient, the amount of radiation delivered by
the linear accelerator must be quantified. This is done by the use of ‘monitor units’
(MU), which is analogous to the length of time the radiation is on for. The MU to
dose relationship can be considered similar to the power and luminosity of a light
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bulb. A bulb cannot be defined as having a single absolute luminosity – the brightness
will depend not only on the power of the bulb, but the distance of the observer, the
angle at which it is observed and the presence of any matter between the bulb and
observer, amongst other things.
In order to calculate the dose delivered from MU or vice versa, the monitor unit is
calibrated such that under a certain set of conditions, a known dose is delivered to a
reference point. At the Princess Alexandra Hospital (PAH), 1 MU delivers 1 cGy to a
point at the isocentre at 10 cm depth in water, using a 10 × 10 cm2 square field. From
this core information, an assortment of measured conversion factors for different field
sizes, depths and positions off axis can be used to mathematically determine the dose
to a specified point under a range of conditions.

1.2.3

The Treatment Process

A Radiation Oncologist will prescribe radiation therapy just as any other doctor will
write a prescription for medicine that will relieve a patient’s symptoms. The imaging
of patients, treatment planning and delivery of treatment is undertaken by Radiation
Therapists. Once radiation therapy has been prescribed, the first step in treatment
involves imaging the patient, usually using a CT scanner, to obtain the image data
required for planning. The patient is scanned in the same position that will be used for
treatment, so it is important that the position is both conducive to an effective beam
arrangement and comfortable enough for the patient to remain still for a treatment that
ordinarily takes between 20 and 30 minutes.
The CT will reconstruct many transverse slices across the region of treatment, which
are then transferred to the treatment planning system to create a 3D representation of
the patient. The CT data is the source of not only the geometry of the patient, but
contains the attenuation properties of the different tissues and structures throughout
the body.
The Radiation Oncologist then outlines the region that is to receive the prescribed
dose, known as the Planning Target Volume (PTV). The Radiation Therapist will then
use the treatment planning system to create a plan of custom field sizes, angles and
MU for each field that covers the PTV in a dose that is as uniform and close to the
prescribed dose as is reasonably achievable, while minimising the dose outside the
PTV.
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Figure 1.9 Example of a treatment plan showing the calculated dose distribution. In this
case there are multiple PTVs that have been contoured in translucent red.

Once the plan is accepted by the Radiation Oncologist and has passed several stages
of quality assurance, the patient will commence treatment, each day receiving a
fraction of the total MU depending upon the fractionation schedule prescribed. The
patient is set up on the treatment couch according to the position and location
determined at the time of CT scanning. Once ready to begin, there are methods of
verifying the patient position before commencing the treatment, most commonly the
use of an Electronic Portal Imaging Device (EPID). The EPID is a flat imaging panel
that produces a 2D image from attenuation of the MV photon beam. By taking two
orthogonal images the patient position can be verified by referencing the position of
bony landmarks and a shift made if required. Onboard kilovoltage (kV) X-ray
imaging systems are becoming increasingly common, which can be used to generate
planar images or utilise gantry rotation to produce a cone-beam CT (CBCT) for 3D
position verification.

17

Chapter 1: Introduction

1.3

Equipment in a Radiation Therapy Department

1.3.1

Computed Tomography Imager

As mentioned in the previous section, a CT scan is the first procedure undertaken for
most radiation therapy patients. Before CT scanners became prevalent in modern
radiation therapy, a simple kV planar imager known as a ‘simulator’ was used to take
initial X-ray images of a patient to assist with planning. For this reason, a CT scanner
is often referred to as a CT-Simulator in radiation therapy.
The advantages of using a CT to image patients are numerous. Firstly, a CT provides
a 3D data set of images, by collecting multiple slices. This, combined with the ability
of CT to show soft tissue structures rather than a 2D attenuation map as in a
conventional X-ray, means that treatments can be planned accounting for specific
internal anatomy, rather than assuming the body is a volume of homogeneous tissue.
Unlike a diagnostic CT scanner, the purpose of which is purely to produce a clear
image for visual interpretation, a CT used for radiation therapy must satisfy additional
functions and these must be carefully maintained. In basic design, a CT-simulator is
no different from a diagnostic CT, except for a flat couch and movable external laser
system used to assist in marking reference points on the patient.

Figure 1.10 A Toshiba Aquilion scanner at the Princess Alexandra Hospital, showing the
laser apparatus in front of the CT bore.
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Figure 1.11 Patients receiving treatment to the head and neck region are usually secured to
the couch in a custom immobilisation mask. This not only prevents movement, but allows
positional markers to be permanently drawn onto the mask rather than tattooed onto the
skin as is common in other areas.

The other primary difference between a diagnostic CT and one used for radiation
therapy is that in addition to providing a quality image, the radiation therapy image is
also the source of the both spatial and electron density data used by the treatment
planning system to calculate attenuation and scatter of the radiation. It is therefore
crucial that the scanner is not only maintained to give a clear, artefact-free image, but
one that is geometrically and physically accurate.
A CT image is acquired using a rotating kV x-ray source and detector assembly
through which the patient couch slides, taking transverse slice images as the patient
moves through the beam.
Reconstruction of an image is performed using back-projection of the acquired data,
essentially a virtual reversal of the acquisition process. Each detector response is
back-projected from its point of acquisition toward the source, such that the
summation of these views where they intersect reproduces the structure that was
imaged. When the raw view is used, the reconstructed image suffers from blurring
and lack of clarity. Special reconstruction filters applied to the projections provide a
sharper more resolved image.
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Figure 1.12 The internal components of the Toshiba Aquilion CT, showing the x-ray
source (top) and detector array (bottom). The large bore CTs are popular in radiation
therapy as they allow extra room for certain treatment positions.

Figure 1.13 Demonstration of tomographic reconstruction using filtered back-projection to
produce an image slice. Each box shows the results of using an increasing number of
projections – naturally the more projections used the better the resultant image. Picture
used with permission from ImPACT: www.impactscan.org
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Each image slice consists of an array of volume elements or voxels, the size of which
is determined by the slice thickness and 2D matrix resolution. Upon reconstruction,
the CT image display will provide a set of slices in which each voxel in the slice is
viewed as a 2D picture element or pixel. For each pixel, the linear attenuation
coefficient is calculated by the software and used to assign the pixel a CT Number,
also known as a Houndsfield Unit.
CT Number = 1000 ×

µ pixel − µ water
µ water

Using this formula, the CT Number for water becomes zero, for air (very low µ) the
CT Number approaches -1000 and for bone the number can be hundreds or thousands.
The slices are then viewed as a set of 2D greyscale images, traditionally with high
density areas such as bone in a lighter shade and low density air or lung shown in a
darker shade. The greyscale representation can be adjusted to different window levels
and window widths, which tailor the range of CT Numbers across which the greyscale
is applied. To observe higher contrast in a particular area the window width can be
reduced to match CT numbers in that region. This will offer better definition in the
local region however will saturate pixels of higher or lower CT Number to white and
black. The window level is the CT Number in the middle of the window.

Figure 1.14 The concept of window level (WL) and window width (WW) can be seen in
this figure, with a graphic demonstration of how the greyscale can be adjusted across the
HU range. On the left, the WL is brought down so that the lung tissue can be distinguished
at the expense of soft tissue definition. On the right is a more typical CT view, with a focus
on soft tissue definition by having the WL close to zero. The WW here is around 1000, so
everything with a CT number of less than about -500 appear black, and areas of HU>500
appear white. Picture used with permission from ImPACT www.impactscan.org

Using the CT data set, a Digitally Reconstructed Radiograph (DRR) can be produced,
which is a planar image resembling a conventional 2D x-ray image. Usually
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constructed for coronal and sagittal views, these can then be compared to real-time
imaging during treatment in order to verify the patient position.

1.3.2

Treatment Planning System

Modern radiation therapy centres use a complex computerised treatment planning
system (TPS) in order to deliver accurate dose to a patient. When a new treatment
machine or TPS is commissioned, a series of measurements are undertaken to
characterise the treatment beam. The TPS will specify the data that needs to be
collected and these measurements are then entered into the TPS to be used as
reference data for all future calculations. The planning software uses the stored beam
model in conjunction with patient anatomical data and user-specified beam angles and
field shapes and sizes to perform 3D dose calculations.
After a patient has been scanned using a CT, the first step is to import the CT data
into the TPS. The TPS assembles the CT slices into a single volume, interpolating
between slices to provide a smooth continuous volume. The 3D patient data is
represented by displaying three 2D images as shown in figure 1.9.
The patient anatomy can now be accurately viewed to allow planning targets and
organs to be outlined, however to perform dose calculations the physical properties of
the tissues must be known, most notably, the electron density. The electron density
(ED) is determined from the CT Number using a measured relationship known as the

Figure 1.15 The electron density phantom used at the PAH features room for 16 inserts of
known electron density, representing various types of tissue. A vial of true water,
RED=1.00, is also included.
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CT-ED curve that is formed by imaging a phantom with inserts of known ED and
plotting against the resultant CT Number. As the calculated CT Number is derived
from the attenuation coefficient of the medium, the number given will vary depending
on the tube voltage used, and may also exhibit a small dependence on scan parameters
such as tube current, field-of-view size, slice thickness and reconstruction algorithm.
If the variability of CT Number with these parameters is outside recommended levels,
more than one CT-ED curve will need to be established and used with the relevant
imaging protocol. Electron densities of subjects are commonly referred to by their
relative electron density (RED) to that of water. Once the initial beam arrangements
have been made, the TPS calculation algorithm can determine the dose throughout the
plan based on the electron densities of the various tissues. The electron density
information obtained from the CT data is used to correct for both attenuation and
scattering of the beam as it passes through a medium. When a medium has higher or
lower electron density than water, more or less attenuation will result respectively
when compared to the behaviour of the beam in water. Where the beam has transited
an area of such an inhomogeneity, it is useful to consider the water equivalent depth
(dwater) of a point of interest, rather than the actual physical depth (dmed):

d water = d med × REDeff

(Khan et al, 1991)

When multiple media are involved, the water equivalent depth can be defined as the
sum of the product of the RED and distance travelled through each pixel, tissue type,
or grid point:
d water = Σ(d i × REDi )

1.3.3

Linear Accelerator

Commonly known as a linac, the medical linear accelerator is the most common
treatment machine used in modern radiation therapy and capable of delivering both
high energy photons and electrons. While different manufacturers develop their own
trademark phrases and technologies to market their machines, the basic principles of
operation remain the same. The PAH currently operates five Elekta (Crawley, UK)
linacs, all of which have Electronic Portal Imaging Devices (EPID), Multi-Leaf
Collimators (MLC) and multiple energies and modalities.
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Figure 1.16 This image shows the linac at the nominal 0° orientation, with the source head
at the top of frame and EPID panel below the treatment couch. This machine also features a
cone-beam kV source (retracted, at 3 O’clock) with a second detector panel (9 O’clock) that
can be used to acquire a CT image of the patient on the couch.

The radiation beam begins with the thermionic emission of electrons from a heated
cathode known as an electron gun. The electrons are focussed and accelerated through
a perforated anode where they enter the accelerating waveguide. The accelerating
waveguide is an evacuated tube divided into a number of cavities through which a
high power microwave propagates. Both the electron gun and microwave source are
supplied with a pulsed voltage that is generated from a complex modulator. The
electrons are accelerated close to the speed of light by the magnetic fields of the
microwave, before a series of magnets directs the electron beam downward towards
the patient.
In the case of electron treatment, the electrons simply continue through the series of
monitoring and field shaping systems before leaving the machine. For a photon beam,
the electrons are first focussed onto a Tungsten target where bremsstrahlung X-ray
production occurs (discussed in 1.1.1).
The photon beam travels through a long conical primary collimator and passes
through a flattening filter to correct for the decreasing intensity away from the centre
of the beam. From there, a series of ionisation chamber detectors monitors the flatness
and symmetry of the beam, as well as the uniformity, dose rate and output. The beam
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will terminate if any of the values exceed set tolerances, or under normal
circumstances will end the beam delivery when the preset MU is reached.
On Elekta linacs, all of the abovementioned systems are fitted to a large rotating
assembly that spins in a vertical plane about an axis that coincides with the isocentre.
The movement of this section of the linac allows the beam to be directed from above,
below or either side of the patient and the angle specified is known as the gantry
angle where at 0° the treatment head is at its topmost position pointing down.

Figure 1.17 The Elekta linacs house all components inside a rotating drum that, once
installed, is hidden behind a fascia wall. The waveguide runs inside the angled frame
protruding from the top of the drum. Suspended from the end of the frame is the rotating
collimator.

The section of the treatment head beyond the ion chamber system houses the internal
wedge filter (used to induce an intensity gradient across the field), the light and mirror
system used to visualise the field and the collimating jaws and/or MLCs to define the
size and shape of the field. This section must be able to spin about the axis of the
beam so that the wedge and jaw orientation can be positioned appropriately for the
treatment area. As a whole, this part of the machine is referred to as the head or
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collimator, and the 0° collimator angle is defined where a particular jaw runs

perpendicularly to the gantry’s plane of rotation.

1.3.4

Electronic Portal Imaging Device

The EPID is a ubiquitous and versatile accessory to the modern linac that is used
primarily for the verification of patient positioning before treatment. Before the
introduction of the EPID, film was used beyond the patient to image their anatomy
using the photon treatment beam. The advent of online portal imaging provided
instantaneous verification of patient positioning, with fast detection and correction of
localisation errors and no need for a supply of consumable film.
When a portal image is taken, the field shape and anatomy can be verified against a
saved DRR from the CT planning data. Any offset in patient set up can then be
accounted for by moving the treatment bed vertically, laterally or longitudinally. The
frequency with which the EPID is used throughout a full treatment course will depend
on the treatment site, the extent of immobilisation devices used and the fractionation
of the treatment, amongst other things.
The most commonly used EPIDs today are amorphous silicon (a-Si) detectors, which
are implemented by Varian (PortalVisionTM), Siemens (OptiVueTM) and Elekta
(iView GTTM) as used at the PAH (van Elmpt et al, 2008). The a-Si EPID features a
thin metallic plate that produces electrons from Compton interactions; these electrons
are then absorbed in a phosphor screen with the emission of a low energy photon. An
array of small photodiode detectors then detect the light and produce a greyscale
image for display.
The panels at the PAH feature a 1024 × 1024 pixel detector, with a pixel size of 0.25
mm at the isocentre plane. The detector is synchronised with the modulator that
controls pulsing of the accelerator’s electron gun so that the data is read in the time
between each radiation pulse. The data from each diode is combined and sent as a
single packet directly from the detector panel to the framegrabber in the iViewGT
computer. Once an entire frame has been sent, the detector panel triggers the detector
control board to send a data packet to the iViewGT computer to allow processing of
the data and image construction. The resultant image is overlayed against a saved
DRR, using specific anatomical features (usually bony processes) to determine any
offset in the patient setup.
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Figure 1.18 The iView GT EPID panel as fitted to the Elekta AxesseTM at PAH.

Figure 1.19 The Elekta iViewGT EPID panel. Electrons are stimulated in copper via
Compton interactions. The electrons strike the scintillating layer of Kodak LANEXFastTM,
a terbium-doped gadolinium oxysulfide, and the resultant light is detected by photodiodes.
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2. Previous Work and Purpose of Experiment
2.1

Literature Review

Evidence for the concept of an Electronic Portal Imaging Device dates back to the
1950s, when several groups published the use of crude image intensifier and camera
based systems to monitor X-ray treatments in real time (Strandqvist and Rosengren,
1958, Andrews et al, 1958, Wallman and Stalberg, 1958). It was not until the late
1980s that EPIDs became widespread, with the first generation of commercially
available devices finding popularity. These products employed either a development
of the early video based systems (Leong, 1986, Shalev et al 1989, Munro et al 1987,
1988, 1990a, 1990b) or a scanning ion chamber design developed by Nederlands
Kanker Instituut (NKI) (Meertens et al 1985, 1990, Van Herk and Meertens 1987,
1988, Van Herk 1991, Van Herk et al 1992). The 1990s saw the emergence of modern
amorphous silicon detectors, with development and implementation lead by Antonuk
et al (1996).

Primarily EPIDs have been designed for localisation and verification of the target
volume position within the treatment beam, however they are increasingly being used
for secondary purposes. Radiation therapy departments including the Princess
Alexandra Hospital are using the EPID to perform many types of physics
measurements that have traditionally required film (Curtin-Savard and Podgorsak,
1997). Quality assurance testing of radiation field size, coincidence of light and
radiation fields and MLC calibrations are examples of processes that can be
completed conveniently with an EPID, using anything from simple in-house analysis
programs to proprietary software & hardware packages.
Dosimetric applications are numerous, including the verification of intensity
modulated treatments where patient specific measurements are required. The EPID
can be used to measure 2D fluence maps with the instantaneous digital acquisition
that has made array detectors popular, but with much better resolution than that which
comes from using such devices. These quality assurance measurements are primarily
a test of the linac delivery rather than TPS accuracy, and will identify any flaws in the
delivery of the treatment plan.
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In addition to these traditional pre-treatment verification measurements, the capability
of EPIDs in conducting actual dose measurements is currently being realised through
a variety of methods. One step beyond 2D fluence map verification is a method that
uses these measured fluence maps to then recalculate the patient dose based on the
delivered fields. This data is collected without a patient or phantom in the field
(known as non-transmission or non-transit EPID dosimetry), so that the dose
distribution collected at the detector plane is an accurate representation of the fluence
delivered by the machine. A dose calculation on the patient CT data can then be
performed, either using the original treatment planning system (TPS) (Steciw et al,
2005) or by using a second independent TPS (Renner et al, 2005). This provides a
more intelligible view of the plan accuracy as the actual 3D dose distribution can be
visualised in terms of the patient anatomy, and clinical consequences can be identified
both qualitatively and quantitatively by means of Dose Volume Histograms. By
comparison, reporting a dose difference in a single 2D fluence map provides no direct
information on the actual dose distribution, and one can only speculate as to what the
clinical consequence might be.
Transmission or transit measurements have been used in 2D verification by
comparing a measured image (ultimately during actual patient treatment) with a
calculated 2D dose map from the TPS. This can either be performed at the detector
plane as in non-transit techniques (van Elmpt et al, 2005) or by utilising a backprojection algorithm, at a plane in the patient (Boellaard et al, 1998). The pinnacle of
EPID dosimetry is the use of a 3D back-projection algorithm to calculate 3D patient
dose distribution based on the actual beams delivered. As pre-treatment verification
would still take place, these measurements would serve mostly as a test of the patient
setup and anatomy, revealing the effects of any weight loss or other inconsistency
between the planning CT session and treatment. Ideally, the back projection would be
applied to patient image data taken at the same time, such as that acquired with a
gantry-mounted cone-beam CT. This then makes retrospective and/or adaptive
treatment planning the next logical step.
Amongst these potential avenues of the future, perhaps the EPID dosimetry technique
most relevant to this project is the simple point dose transit measurement. Conceived
to replace in vivo measurements using diodes, the EPID has been used to check a
single dose value both at the detector plane (Nijsten et al, 2007a) and using backprojection (Pasma et al, 1999).
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Whereas these techniques convert the pixel value into dose for treatment verification,
this project aims to use the pixel information to determine the electron density of a
material based on its transmission properties. The catalyst for this is the prevalence of
artificial implants which can not be imaged accurately using a conventional CT
scanner. High density materials such as steel and titanium cause artefacts in a CT
reconstruction due to the attenuation properties of heavy materials in the kilovoltage
beam, in turn preventing a realistic CT-ED calculation. Using the higher energy beam
of the linac to measure the electron density of the material would allow correct data to
be manually entered into the treatment plan. With the number of joint replacements in
Australia steadily increasing (Australian Orthopaedic Association National Joint
Replacement Registry, 2013), the occurrence of radiation therapy to sites with such
implants will increase and the ability to accurately identify the prosthesis material will
become ever more important.

The current PAH planning protocol for patients with metal implants is for the
radiation therapist to outline the implant structure, assign the correct CT number
(where possible) and perform standard artefact corrections to any affected tissue.
The literature provides examples of how other groups have attempted to correctly
resolve the electron density of metallic implants. In 2003 Coolens and Childs
experimented with an extended CT scale, whereby the HU range is scaled so that high
density metals do not exceed the maximum limit. This reduces artefacts and provides
improved definition of the metallic structure at the expense of contrast resolution. The
authors attempted to calibrate the scaled CT to electron density using two different
methods; however neither could successfully predict the true electron density of the
materials. It was concluded that, while actual electron density could not be accurately
measured, the results were able to sufficiently distinguish between the lower density
titanium and higher density stainless steel and cobalt-chromium. As the geometry of
the implant was able to be accurately outlined, the recommendation was to then assign
the correct density in the TPS, as is done at PAH.
Increasing the energy of the imaging beam has been investigated by several groups.
Yang et al (2008) published results using a makeshift orthovoltage computed
tomography unit (OVCT). This comprised of a bench mounted X-ray tube, flat panel
detector and a rotating platform upon which a phantom was placed. The orthovoltage
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source could be adjusted from 40 to 320 kVp, much higher than the conventional CT
energy of around 100 kVp. This provided a marked improvement in artefact
reduction, with the measured electron densities significantly closer to the true value
than when using kilovoltage CT. The OVCT results were reported to be an effective
compromise between minimising metal artefacts and maintaining sufficient soft tissue
differentiation. The use of a true MVCT, either with a TomoTherapy machine or a
linac cone beam, offers limited planning information for conventional tissues due to
the loss of low contrast resolution.
Thomas et al (2011) investigated the fusion of MVCT with kVCT, having concluded
in a previous study (2009) that MVCT did not have adequate contrast and resolution
to be used independently for treatment planning. This appears an attractive solution,
however if the usefulness of the MVCT is limited to determining the composition of
the insert rather than being used directly in planning, justification of the significant
patient dose involved in MVCT can be questioned when a simpler alternative may be
able to provide the same information.

2.2

Project Objectives

This project aims to establish a method of determining the composition of metallic
prostheses that requires little or no additional dose to the patient, results in minimal
disruption to current practices and workload, and can be designed and implemented
with judicious use of resources and a level of complexity that is proportional to the
clinical outcomes.
The technique should also have the required accuracy for use in the commissioning of
phantom materials, where small variations in properties can have important
dosimetric implications.
Initial studies characterise the response of the Elekta iViewGT EPID, devising a way
to extract a usable integrated response and confirming the linearity of the detector
with a change in monitor units, thickness of absorber and electron density of the
absorber.
Previous studies have found the long term response of EPID images to be acceptable
for this project (Louwe et al, 2004), and the response changes predictably with dose
(Antonuk et al, 1998, McDermott et al, 2004, El-Mohri et al, 1999). Variance due to
beam hardening has been outlined as an issue (Parent et al, 2006, Nijsten et al, 2007b,
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Greer 2005, 2007), as the solid state detectors used in EPIDs are noticeably energy
dependent.

A technique is developed in which a single MV field is used to emulate the function
of an MVCT by making a measurement of the electron density of an unknown
material using the dimensions and densities of the surrounding medium of known
density.
The application of the method to a homogeneous phantom is investigated in order to
test the ability of the approach to distinguish very similar materials.
A comparison between the electron densities determined by this technique is
compared to those measured by CT and MVCT and the differences analysed. The
effect of discrepancies between kV and MV imaging on the phantom dose calculation
in a treatment planning system is evaluated.
Finally, a metallic hip prosthesis is used to undertake a realistic assessment of the
potential for the technique to be used clinically for patient plan verification.
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3. Development of an RED Calculation System
3.1

Initial Characterisation of the EPID

Prior to commencing measurements, it was essential to properly test the fundamental
properties of the Elekta imaging system to ensure a predictable response to the range
of parameters that are likely to be used, and the usefulness of the data generated.
Ordinarily, only image quality and geometric accuracy are of importance in the EPID
system and actual pixel information is unused.
These measurements were undertaken with a 6MV photon beam, the thought being
that the energy with the most pronounced attenuation would be desirable for
distinguishing between phantoms of different densities and thicknesses. A 20 × 20
cm2 square field was used with the couch top at 100 cm SSD, and the central
(512,512) pixel of the EPID used for analysis of results.
The iViewGT software records an image in a number of frames, and the resultant
picture is normalised so that saturation of the available pixel values (0 - 65,536) does
not occur. This means that an image will look the same regardless of the number of
MU used to create it. Unfortunately, it also means that for an open field, the pixel
values forming the image will be not be dependent upon the amount of radiation
measured by the detector, and forms only a relative intensity map. Within the
iViewGT software, the Pixel Scaling Factor (PSF) for an image can be retrieved, and
it was found that dividing the displayed Pixel Value (PV) by the PSF would give a
value representative of the amount of radiation delivered. This term was defined the
Integrated Pixel Value (IPV).

Pixel Value
= Integrated Pixel Value
Pixel ScalingFactor
The PSF is a value assigned to each acquired image as a whole, and applies to every
pixel in the image. Therefore, the IPV for a particular region of interest is found from
the average pixel value in the region of interest divided by the PSF for that image.
Comparison of PV or PSF alone between images is not necessary, as the same
acquisition could have a marginally higher PV and would have a higher PSF to
compensate.
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This was first tested with a simple case of increasing MU, which showed a
corresponding linear change in IPV (figure 3.1) for a single acquisition for each
number of MU using the setup described above. Subsequent tests verified linearity to
1000 MU, far in excess of the foreseeable range of use.
Back-to-back measurements were found to have a standard deviation of around 0.5 %,
and the measured values were found to be independent of SSD within this uncertainty.
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Figure 3.1 Linearity was verified with no sign of saturation. Error bars are within the
size of the markers

Three Gammex tissue equivalent materials were acquired for use in this project. The
slabs are designed to simulate lung, inner bone and cortical bone in an MV photon
beam. Initially, a simple test was performed in which 2 cm thickness of each material,
as well as 2 cm of Plastic Water, was given a 10 MU delivery in turn to check the
response of the EPID panel. Rectangular phantom blocks were placed flat on the
treatment couch with the main 30 × 30 cm2 face perpendicular to the beam. Again, a
20 × 20 cm2 square field was used with the couch top at 100 cm SSD so that all parts
of the radiation field passed through the phantom. The IPV was observed to decrease
as the exposed phantom increased in density. Across the range of available data
points, a linear approximation was found to pass just within the range of experimental
uncertainty, corresponding to approximately 0.5 % reproducibility, and was used as a
starting point to develop a IPV-to-RED formula.
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Figure 3.2 Acquisitions with no attenuator, lung slab (RED 0.292), Plastic Water
(RED 0.995), Inner Bone (RED 1.086) and Cortical Bone (RED 1.692) showed a
linear response of the imager to the variation in RED.

3.2

Developing an IPV-RED Formula

The project objective was then to produce an experimentally-derived formula in
which RED can be calculated based upon the measured IPV and other parameters.
Because possible effects due to the object’s mass density and atomic number cannot
be completely discounted, the result is given as REDeff: an “effective” relative
electron density which takes into account the attenuation of the specific megavoltage
photon source used to acquire the images. For the application at hand, a quantity of
REDeff measured in the user beam quality is actually more relevant than true RED.
Use of RED as the sole parameter for a medium in treatment planning systems
incorrectly assumes that the beam interactions depend solely on this quantity, and the
use of an experimentally derived REDeff inherently contains a radiation beam qualityand material-specific indication of water equivalence. The formula would be
developed gradually to incorporate increasingly complex measurement variations.
Using the gradient and intercept of the graph in figure 3.2, an initial formula was
found that would operate for an absorber of 2 cm thickness, using any number of MU.

REDeff =

− IPV
+ 11.9
557 × MU

(3.1)
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The next variable to be investigated was the thickness of the absorber. The
thicknesses that could be imaged were limited by the number and size of the Gammex
tissue equivalent slabs. The lung blocks available were one each of 1 cm, 3 cm and 4
cm slabs and two 2 cm slabs, one of which was eventually cut down into nine smaller
squares. Two 2 cm blocks of inner bone were available, and cortical bone was stocked
in 0.2 cm, 0.3 cm, 0.5 cm and two 1 cm thicknesses. As a result, the only common
size that can be configured across all phantom types is 2 cm. Plastic Water phantoms
could be constructed to any thickness up to 40 cm in 1 mm increments.
Data was collected for a range of attenuator thickness from 5 mm to 10 cm. As in the
previous section, a 6 MV 20 × 20 cm2 photon beam was used with the phantom
materials placed face down on the treatment couch that was at 100 cm SSD. A single
10 MU image was collected for each thickness of each phantom, with the central pixel
of the EPID used for analysis of results. In each case, all phantom materials that could
be configured to that thickness were used.
From the measured data, straight lines of best fit were inserted to intersect at the point
where no attenuator was present. The slope of each line was then analysed so that the
IPV-REDeff relation could be made to include a function of thickness.
In these results the slope appeared to be linearly dependent upon the thickness, t, with
an average S/t value of 2804. The formula was developed to include this dependence,
as well as accounting for attenuation as the difference between the IPV with absorber
and the IPV with a bare treatment couch, IPV0, rather than as an absolute value.
EPID Response to Attenuators of Varying RED and Thickness
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Figure 3.3 The IPV-RED relation for phantoms of increasing thickness.
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Table 3.1 Comparison of the gradient information for the data in figure 3.3.
Thickness (t, cm)
0.5
1
2
3
4
5
10

Slope (S)
1435
3070
5689
8410
11605
13541
24330

S/t
2870
3070
2845
2803
2901
2708
2433

Measurement of IPV0 at the same time as the IPV would minimise the effect of daily
variation in the EPID response by measuring the actual attenuation as a reduction in
pixel value.

RED eff =

IPV0 − IPV
280 × t × MU

(3.2)

Working towards a clinical implication, the next goal was to establish a way of
accounting for transmission through two or more different materials. An adaptation to
the formula was considered in which the attenuation attributed to a known component
is subtracted from the total attenuation, leaving the amount of attenuation (in pixel
values) that is caused by the unknown material.

For transmission through a two-part absorber, the hope was that overall attenuation
could be estimated as:
Total Attenuation = Attenuation from Part A + Attenuation from Part B
or, where one part is a known substance and the other unknown,
IPV0 − IPVtotal = (IPV0 − IPVknown ) + ( IPV0 − IPVunknown )

(3.3)

Rearranging equation 3.2, the attenuation caused by a single substance is given by:
IPV0 − IPV = RED eff × 280 × t × MU

(3.4)

Substituting into equation 3.3 and rearranging, the unknown REDeff can be found by:
RED eff ,unknown =

IPV0 − IPVtotal − (REDeff ,known × 280 × t known × MU ) (3.5)

280 × t unknown × MU

where IPV0 and IPVtotal are measured quantities, REDknown is a suitable value for the
known substance and the thicknesses are taken from a CT or orthogonal planar image.
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To test the accuracy of this hypothesis, an assortment of compound phantoms was
imaged that would allow a comparison of the formula’s performance in various
stages. The phantom arrangements shown in figure 3.4 were placed on the treatment
couch at the isocentre and given 10 MU with a 20 × 20 cm2 6 MV field. In these
measurements, two acquisitions were made for each arrangement, and the average
central pixel value used for analysis. The average of five measurements of IPV0 was
used in conjunction with all other measurements.
In each phantom, the REDeff for each component was calculated by assuming the
other component to be the known substance. Firstly, each tissue equivalent material
was imaged with a Plastic Water block. Secondly, a series of bone/water phantoms
was imaged in which the amount of each material was varied while keeping the same
overall thickness. Finally, a series of bone/water phantoms was used in which the
overall thickness increased. The results, shown in figure 3.4, showed that formula 3.5
did not accurately model the attenuation from a compound phantom. Most evidently,
as the overall phantom thickness was increased, the error in the calculated REDeff of
both components escalated to the point where a 1 cm thickness of bone was
determined to have a negative density when imaged with 10 cm of Plastic Water on
top.
To better model the dependence of the formula on thickness, a more substantial set of
calibration data was acquired by collecting over a greater range and at more closely
spaced intervals. Original thickness data was acquired up to 15 cm for Plastic Water,
and limited by availability to 10 cm lung, 4 cm inner bone and 3 cm cortical bone. By
cutting one of the 2 cm lung slabs into 9 smaller squares, a much thicker lung
phantom could be created meaning calibration data could be acquired over a larger
range.
It was also decided to move from a 20 × 20 cm2 field to a narrow 2 × 2 cm2 field in
order to maximise the primary component of the beam and minimise the proportion of
scattered radiation that was contributing to the image. All other setup and analysis
methods were unchanged. The formula still relied upon a linear approximation of the
panel response to increasing RED in the measurement range, and the linearity
between panel response and RED was shown to improve with decreasing field size,
due to partial occlusion of the x-ray source or insufficient detector signal. The
difference between the 2 cm and 20 cm response curves is displayed in figure 3.5,
with other field sizes omitted for clarity.
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Figure 3.4 The test results and depiction of phantoms used for verification of equation 3.5
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Figure 3.5 The attenuation versus RED is more linear at small field sizes

The extended calibration data set (figure 3.6a,b) revealed an interesting occurrence.
Logically, the slope of each trendline, representing a certain phantom thickness,
would converge to 47000, the IPV0 measured during this data collection, as the RED
approached zero. It was found that setting this convergence did not produce an ideal
fit to the data, with the fit getting worse with increasing thickness.

EPID Response to Attenuators of Varying RED and Thickness - Converge to 47000
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Figure 3.6a The IPV-RED relation graphed with a convergence to IPV0 at RED=0
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EPID Response to Attenuators of Varying RED and Thickness - Not converging
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Figure 3.6b The IPV-RED relation was graphed with a raw fit between the data points.

The relationship between thickness and gradient was compared for both scenarios.
Unlike the previous results shown in table 3.1, these more extensive data sets showed
that the slope was not a first order function of thickness, but gradient slowed with
increasing thickness (table 3.2).

Table 3.2 Comparison of the gradient information for the data in figure 3.6.
Thickness
Converge to 47000
Not Converging
(t, cm)
Slope (S)
S/t
Slope (S)
S/t
1
2267
2267
2232
2232
2
4449
2225
4637
2319
3
6591
2197
6402
2134
4
9208
2302
9641
2410
5
10712
2142
11029
2206
6
12491
2082
12412
2069
7
14175
2025
13652
1950
8
15548
1944
14947
1868
9
17358
1929
15987
1776
10
18834
1883
17383
1738
12
21487
1791
19403
1617
14
23702
1693
21390
1528
16
26276
1642
22493
1406
18
28312
1573
24076
1338
20
29981
1499
24929
1246
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A polynomial fit was applied to quantify this trend, and the formula adapted to reflect
a second order dependence on thickness. For the case of data converging to 47000, the
formula became:

REDeff ,unknown =

{

(

)

2
IPV0 − IPVtotal − REDeff , known × − 4t known
+ 230t known × MU

(− 4t

2
unknown

}

(3.6)

)

+ 230t unknown × MU

And the non-converging data gave the relation:

REDeff ,unknown =

{

(

)

2
IPV0 − IPVtotal − REDeff ,known × − 5.5t known
+ 230t known × MU

(− 5.5t

2
unknown

)

+ 230t unknown × MU

}

(3.7)

In order to assess the formulae, both new equations and the original equation 3.5 were
rearranged to show the expected IPV for a homogeneous phantom of known RED,
and compared to the measured data (figure 3.7). The equation 3.6 was found to be the
most accurate model of the measured data. Plastic Water and the lung phantom were
used for these calculations as these materials had the greatest range of data collected,
up to 20 cm thickness. Having modelled the homogeneous data more accurately by
replacing the linear thickness relation with a polynomial component, the new formula
was then tested against the series of phantom combinations used earlier. The
calibration conditions of 6 MV, 2 × 2 cm2, 100 cm SSD, and two 10 MU
measurements were maintained, with analysis again using the central pixel value. It
was unfortunate to see that, despite the new formula showing increased accuracy in
modelling uniform absorbers (figure 3.7), calculations involving transmission through
multiple materials were far from adequate. In contrast to the improved fit to the input
data, the output of the formula had gotten worse (figure 3.8).
It was thought that this could be due to the emphasis on water and lung equivalent
materials in developing the formula. The fact that the test phantoms predominantly
involved cortical bone meant that the extrapolation to higher RED would have to be
accurate. Another round of data collection was undertaken, again with water and lung
data taken for up to 20 cm thickness but this time including the bone phantoms where
possible as well. This made marginal difference to the formula and end results
remained inaccurate.
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Figure 3.7 Each established equation was tested against measured data of Plastic Water and
lung phantoms to evaluate how closely the expected IPV matched the experimental results.
The best fit was found to be equation 3.6.

At this point the development of a multivariable formula was abandoned as a viable
solution to the project. It appeared that the hypothesis that the overall attenuation was
equivalent to the sum of the discrete attenuation through each component was untrue.
This is due to the non-linear attenuation of the beam, as well as the hardening of the
beam spectrum as it passes through an absorber resulting in a change in response
from the EPID detectors. As seen in figure 3.9, the attenuation in pixel values per unit
length, akin to a linear attenuation coefficient, actually changes throughout the
phantom. The first 1 mm of water shows a large amount of attenuation, where much
of the low energy radiation to which the EPID over-responds is removed from the
beam. After this section there is a fairly steady decline in attenuation as the beam
hardens and the spectrum shifts towards more penetrating particles.
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Figure 3.8 The test results and depiction of phantoms used for verification of equation 3.6
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In explicit terms, this means that a certain thickness of absorber on its own will not
cause the same reduction in IPV as it would if the beam were to have already
penetrated an additional absorber, and hence this approach to REDeff calculation does
not work.
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Figure 3.9 The attenuation caused by a certain thickness of absorber varies according to the
overall depth of the section.

3.3

Water Equivalence Method

The approach of developing a direct multivariable formula to calculate REDeff became
problematic, and therefore another method was devised that would account for the
attenuation effects as discussed in chapter 3.2. The method also allows for much
simpler initial data collection, only requiring a water equivalent phantom, meaning
that calibrating the system is faster and does not require the use of expensive tissue
equivalent slabs that are not readily available.
Due to availability of treatment machines, all future linac measurements were
performed on an Elekta Axesse, which due to the use of 4 mm MLCs can not produce
a symmetric 2 × 2 cm2 square field, therefore a 2.4 × 2.4 cm2 field was used. Using
6MV and 10MU, data was collected for Plastic Water up to 29 cm in 0.5 cm
increments with three measurements at each point. Images were analysed in ImageJ
(NIH, Bethesda, USA) using a 20 × 20 pixel square region of interest. The results
(figure 3.10) showed a smooth curve analogous to a traditional TPR scan. The
inherent structure of the EPID shown in figure 1.19 is sufficient to establish charged
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particle equilibrium within the imager, so the IPV varies predictably and continuously
with increasing thickness of absorber.

Plastic Water Data Acquisition
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Figure 3.10 The IPV value decreases predictably with increasing attenuation.

When an object is imaged, the measured IPV can then be compared to this data set to
establish the water equivalence of the object. For a homogeneous material, the REDeff
would be found simply by dividing the water equivalent thickness by the actual
thickness. Where an unknown substance is located within another medium, the water
equivalent thickness of the containing medium (based upon its known electron
density) is first subtracted from the overall measured water equivalent thickness of the
phantom before the remainder of the water equivalent thickness is divided by the
thickness of the unknown portion. Strictly speaking, this gives the effective electron
density relative to the calibration material, Plastic Water, and if desired the result can
be multiplied by the RED of Plastic Water, to account for the minor difference in
electron density between it and true water, however this would be insignificant unless
evaluating the accuracy of a water equivalent material.
In a simple example, a 2 cm thick unknown material resides within a water phantom
of total thickness of 12 cm. When imaged, the IPV is 35000 which we know from the
data in figure 3.10 equates to having imaged 15 cm of water. We know that the beam
has passed through 10 cm of water in the phantom, therefore the 2 cm unknown
material is responsible for attenuation equivalent to 5 cm of water. The REDeff of the
material is consequently 2.5.
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A modification to this process was later made where the reference data is expressed
not in terms of the absolute IPV, but the change in pixel values corresponding to an
amount of attenuation, IPVatt, where the IPV is subtracted from IPV0.

IPVatt = IPV0 − IPV
By recording the IPV0 when measurements are taken and using IPVatt, variance in
results due to machine output or detector response fluctuation can be minimised by
focussing only on the relative difference in pixel value related to the attenuation. This
also means the reference values ascend with thickness, making automated
computation of REDeff from the pixel values possible by interpolation in Microsoft
Excel.

Plastic Water Data Acquisition
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Figure 3.11 Calibration data in terms of IPVatt.

3.3.1 Verification Measurements

The approach was first tested using cortical bone and lung slabs with varying amounts
of Plastic Water added. The bone (RED 1.7) or lung (RED 0.3) was treated as an
unknown material and sandwiched between blocks of plastic water so that the beam
passed through both the ‘unknown’ material and a thickness of Plastic Water. The
configurations used are shown in table 3.3. As per the calibration process, a 2.4 × 2.4

47

Chapter3: Development of an RED Calculation System

cm2 6 MV beam was used with the treatment couch at 100 cm SSD. Using a 20 × 20
pixel region of interest, the average of three 10 MU images in each configuration was
used and all measurements of REDeff agreed with the reported RED to within
experimental error. A discussion on the calculation of the listed uncertainties is
provided in section 3.3.4.

Table 3.3 Verification of the water equivalence method for two-part phantoms.
Phantom

Measured REDeff for Bone/Lung

1 cm Cortical Bone + 7 cm Plastic Water

1.7 ± 0.2

1 cm Cortical Bone + 10 cm Plastic Water

1.9 ± 0.3

1 cm Cortical Bone + 15 cm Plastic Water

1.7 ± 0.4

2 cm Cortical Bone + 20 cm Plastic Water

1.8 ± 0.4

4 cm Lung + 20 cm Plastic Water

0.3 ± 0.1

Having confirmed the validity of the concept with tissue equivalent phantoms,
measurements progressed to measuring pieces of various metals that could be
acquired. This was the first attempt at measuring ‘real’ materials, and as such the
shape and thickness of absorbers used varied according to what was available. The
department workshop was able to supply off-cuts of brass, steel, and thicker blocks of
aluminium. Due to the small size and irregular shape of these samples, no plastic
water was added for these measurements, however the setup and analysis was
otherwise unchanged. In contrast to working with phantoms that have an advertised
RED, not knowing the exact composition of each alloy meant for a much more
exploratory task. For the sake of having a theoretical RED to compare against, it was
assumed that steel was iron, brass was 70 % copper and 30 % zinc by weight, and that
the aluminium and lead used was pure.

Table 3.4 Verification of the water equivalence method for dense metals.
Material

Theoretical RED

Measured REDeff

Brass 12.5 mm

6.9

8.0 ± 0.2

Lead 15 mm

8.1

11.5 ± 0.4

Steel 6 mm

6.6

7.0 ± 0.4

Aluminium 10 mm

2.3

2.4 ± 0.2

Aluminium 20 mm

2.3

2.4 ± 0.1
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The resultant measurements (table 3.4) were encouraging; the only major concern was
the value for lead, which was significantly higher than expected. It was noticed that
the measured value was similar to the mass density of lead, and this prompted an
investigation.
It was thought that rather than coincidence, the measured value indicated the
attenuation was dependent on mass density rather than electron density. As detailed in
chapter 1.1.1, the customary thought is that megavoltage photon beams interact
primarily by Compton scattering, which is dependent on electron density. A more
complete description would be that megavoltage photon beams interact primarily by
Compton scattering in tissue. Ordinarily, the equivalent atomic numbers of the tissue
and other materials imaged does not warrant consideration being given to
photoelectric or pair production interactions, but lead is not something one would
encounter in radiation treatment planning. The interaction cross section for lead was
investigated using the NIST XCOM† web program which showed that by the time
atomic number reaches 82, pair production is most definitely a factor in a 6 MV
photon beam, which is dependent on the mass density of the absorber and explains the
result obtained. The method is accurately measuring the water equivalence of lead,
only in this case this is not simply equal to the relative electron density.
Photon Interaction Cross Sections - Lead (Z=82)
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Figure 3.12 Photoelectric effect and pair production interactions are highly dependent on
atomic number and mass density, and are of similar significance as Compton scattering in a
6MV beam.
†

http://physics.nist.gov/PhysRefData/Xcom/Text/intro.html
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3.3.2 Resolution of the technique – comparison of water equivalent materials

Having verified the ability of the technique to broadly identify REDeff in the previous
section, the aim of this section was to determine how well the method could resolve
water equivalent materials with similar RED.
To distinguish between different materials requires the measurement uncertainty to be
less than the difference between the readings from each material. To differentiate
between similar water equivalent products, the experimental setup would need to be
optimised for as minimal uncertainty as possible. The key variables that could be
changed were the sample size and the thickness of the phantom. The use of a thicker
phantom means that the uncertainty in IPVatt is divided across this thickness so that
the overall uncertainty in REDeff is as small as possible. A conflicting effect is that
with increasing depth, the gradient of the relationship flattens meaning that a given
pixel value range equates to an increasingly larger thickness; however this effect is far
less significant. To find the optimal thickness, tests were performed where the same
materials, listed in table 3.5, were imaged in 1 cm, 5 cm and 15 cm thicknesses. For
these measurements five readings were collected for each part, using the standard
setup of 6 MV, 2.4 × 2.4 cm2, 10 MU, a 20 × 20 pixel ROI and the materials placed
on the couch top at isocentre.
Use of a 5 cm phantom allowed much better accuracy than a 1 cm thickness, however
there was far less improvement in going beyond 5 cm to a 15 cm phantom (table 3.5).

Table 3.5 Effect of phantom thickness on measurement uncertainty.
Uncertainty in REDeff measurement

Material
1 cm

5 cm

15 cm

Lung

0.11

0.02

0.01

Water

0.12

0.03

0.02

Bone

0.13

0.04

0.03

To assess the resolution of the technique four ‘water equivalent’ materials were used:
CIRS Plastic Water (Computerized Imaging Reference Systems Inc, Norfolk, USA),
IBA RW3 (IBA Dosimetry GmbH, Schwarzenbruck, Germany), Gammex Solid
Water (Gammex Inc, Middleton, USA) and Perspex blocks of unknown origin. Due to
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availability of materials, 5 cm was selected as the thickness to be used for the
comparison.
To ascertain the limit of resolution, each phantom was placed on the couch top in turn
and imaged ten times using 10 MU and a 6 MV 2.4 × 2.4 cm2 field. The average
IPVatt using 20 × 20 pixel ROIs was plotted against the reported RED to determine
whether the difference in pixel value between the materials exceeded the experimental
uncertainty, indicated by error bars showing the standard error of the mean value. The
Perspex was expected to show a definite difference from the other materials, and
would give an indication on the limit of resolution, if the other materials were not
distinguishable.
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18000
17500
17000
16500
16000
15500
15000
0.9

0.95

1
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1.1

1.15
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Figure 3.13 The EPID response to similar phantom materials.

The results (figure 3.13) show a clear separation between the three water equivalent
phantoms, meaning this procedure can be used to accurately identify the water
equivalency of a phantom material.

3.3.3 Comparison with CT and TomoTherapy

A major goal of this work is to provide a solution to the potential inaccuracy of a CT
in identifying the radiological equivalence in a megavoltage photon beam of certain
materials. The objective of this section is to compare the REDeff of a range of
materials, as measured with the EPID using the technique in section 3.3.2, with the
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RED as determined using conventional tomographic imaging with a clinically
calibrated CT scanner.
For the materials tested in section 3.3.2, the data acquired at that time was used. For
the remaining materials, the listed thickness was similarly placed on the couch at
isocentre one at a time and 6 MV, 2.4 × 2.4 cm2 field size and 10 MU used to acquire
five IPV readings for each phantom, and ten for the shared IPV0.
Each phantom material was subsequently imaged individually on a Toshiba Aquilion
WB CT scanner (Toshiba Medical Systems, Tokyo, Japan), having been laid flat on
the scanner couch in the centre of the bore. On a slice through the centre of each
phantom, a large rectangular ROI was drawn in ImageJ to encompass the bulk of the
phantom, and the mean and standard deviation of the CT Number recorded. RED was
calculated using the clinically used CT-ED table, and the standard deviation in CT
Number converted to uncertainty in RED according to the method outlined in section
3.3.4.
The process used for the CT scans was repeated using a TomoTherapy Hi-ART II
machine (TomoTherapy Inc, Madison, USA) with Twin Peaks accelerator. As a CTED table was not available for this machine, a Gammex Model 467 CT-ED
calibration phantom was imaged at the same time so that a procedure consistent with
the CT scanner could be used for CT-ED conversion. It was expected that the
TomoTherapy MVCT results would be closer to the true RED value than the
conventional CT, due to the imaging beam operating in the megavoltage range, with
peak energy of 3.5 MeV for the incident electron beam (Jeraj et al, 2004).

The EPID measurements proved to more accurately represent the stated electron
density of most materials when compared to the clinically calibrated CT scanner and
MV CT TomoTherapy imaging system (table 3.6). In particular, the CT and
TomoTherapy gave large differences in RED for the lung phantom.

The benefits of calculating REDeff using the treatment MV beam over a standard kV
CT are clearly demonstrated, with the EPID measurements consistently accurate
across the range of materials imaged. The results measured using the EPID are both
correctly arranged in the appropriate order of increasing electron density (top to
bottom, table 3.6), as well as the values themselves being accurate representations of
the reported figures.
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Table 3.6 RED for various materials as computed using different modalities.
Material
Lung (4 cm)
Plastic Water (5 cm)

Reported

Measured REDeff

RED

from EPID

from CT

from MVCT

a

0.28 ± 0.03

0.21 ± 0.01

0.195 ± 0.001

1.046 ± 0.008

0.987 ± 0.001

0.29

0.995

b

0.995

e

Conventional RED

b

1.00 ± 0.01

1.013 ± 0.006

1.032 ± 0.003

1.02

c

1.02 ± 0.01

1.026 ± 0.005

1.042 ± 0.003

Inner Bone (4 cm)

1.09

a

1.10 ± 0.05

1.080 ± 0.002

1.079 ± 0.006

Perspex (5 cm)

~1.15d

1.18 ± 0.01

1.074 ± 0.002

1.148 ± 0.003

1.73 ± 0.06

1.1 – 1.5

1.729 ± 0.005

RW3 (5 cm)
Solid Water (5 cm)

Cortical Bone (3 cm)

1.01

1.69

a

a

Bazalova et al, 2008
Hill et al, 2008
c
Araki, 2012
d
Estimated, based on poly(methyl methacrylate) composition
e
By definition due to calibration technique
b

The CT data, while giving RED with reasonable accuracy for some phantom
materials, failed to correctly order the materials in increasing electron density,
proving that CT response is not dependent upon the electron density alone. In the
kilovoltage beam, the CT Number of the cortical bone varied significantly from the
centre of image to the outer regions, exhibiting the cupping artefact associated with
beam hardening in high-density materials (Kairn et al, 2013), so an accurate electron
density could not be determined.
One would expect that at the very least the materials used to calibrate CT-ED for a kV
scanner would exhibit accurate RED determination when a phantom of identical
composition is scanned, however this was not observed. In the case of this CT, the
CT-ED calibration is configured using the Gammex Model 467 Tissue
Characterisation Phantom shown in figure 1.15. This phantom features, amongst other
materials, the same lung, Solid Water, inner bone and cortical bone materials as used
in slab form throughout this work. The CT Number observed when imaging these
products in slab form, however, was not the same as that observed for a small sample
within a water phantom as in the case of the Model 467 phantom. This was
particularly evident for the lung material. As this very material was used to calibrate
the CT, this particular inaccuracy could not be attributed to radiation interaction
differences in the kilovoltage imaging beam alone, but to the geometric differences
between the calibration and measurement. Further investigation revealed the extent to
which the indicated CT Numbers changed depending upon whether they were imaged
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in situ within the phantom or as standalone objects (Inness et al, 2014). The CT-ED
conversion was found to be heavily dependent on the geometry of the materials used
for calibration.
The TomoTherapy result, using the MVCT imaging function, improved upon the
traditional CT scan, with the materials responding inline with their electron density.
However, the absolute RED values were not as accurate as the EPID measurements,
and same phenomenon observed on the CT was found to occur on the TomoTherapy
scan, where the small lung insert in the calibration phantom returned a vastly different
CT Number to that of the large slab of the same material.
Given the correct ordering of materials with respect to electron density, it is likely that
the TomoTherapy MVCT would provide an accurate measurement of electron density
if the initial calibration was acquired with similar geometry to the test materials;
however this is beyond the scope of this project.
While large rectangular geometries are not encountered in patient anatomy, these
types of phantom arrangements are commonly used for dosimetric verification of a
new TPS or dose calculation algorithm as well as patient specific dose verification.
Any systematic error at the time of TPS commissioning will have a detrimental effect
on every patient treatment thereafter, therefore it is essential that electron density is
correctly assigned regardless of the size, shape or orientation of the scanned object.
The EPID technique used in this thesis is more robust to alternative irradiation
geometries and provides a quick and simple way of determining the RED of a
material in slab form. This is evidently not possible on a clinically operational CT
scanner without the need for additional CT-ED calibration, which would depend on
both the atomic composition and geometry of the material in question.

3.3.4 Discussion of Uncertainty

The final uncertainties given in this work are type A uncertainties based upon the
experimental variation in both the reference data and the test data. For both the
reference and test data, the error in IPVatt is a direct sum of the uncertainty in the IPV
and IPV0 values. In each case the uncertainty is defined by the standard error of the
mean (SEM), given by the standard deviation, σ, divided by the square root of sample
size, n.
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The uncertainties in reference and test measurements are added in quadrature to give
the total error in pixel values. The SEM was calculated for every increment of the
reference data and the largest error used as a worst case solution regardless of the
actual thickness being referenced.

[(

Uncertaint y in pixel value = SEM IPV, ref + SEM IPV0 ,ref

)2 + (SEM IPV, meas + SEM IPV ,meas )2 ] 12
0

As the reference data curve (figure 3.11) is non-linear, a single direct correlation
between uncertainty in pixel value and water equivalent thickness (and subsequently
REDeff) can not be established. A given range of pixel values covers an increasing
range of thickness as the total thickness increases. Furthermore, the transfer of the
error from water equivalent thickness to electron density depends upon the fractional
thickness of the unknown portion of the phantom. As a consequence, in order to
appropriately specify an uncertainty in terms of electron density, the uncertainty in
pixel value as shown above was used to calculate upper and lower confidence limits
of IPVatt. The REDeff was then calculated for these values, in addition to the mean
IPVatt, to give the range of REDeff equivalent to the confidence level of the measured
pixel data.
The uncertainty in RED for the CT and TomoTherapy values was calculated in a
similar way using the standard deviation of the measured region of interest.
The effect of type B uncertainties, such as the electron density of Plastic Water and
thickness of phantom materials, was considered negligible in comparison to the type
A uncertainties discussed in section 2.6. It is also expected that the use of Plastic
Water for calibration, as well as being significantly faster and easier than using real
water, would me more accurate as any uncertainty in phantom thickness would be
much less than the uncertainty involved in physically measuring the depth of water in
a container.
While not discussed in depth in this thesis, preliminary investigations indicate that a
fixed scaling factor could be applied to the IPV to adjust for variability between
different machines, imaging software calibrations or to account for small variations in
machine output between the collection of calibration data and end use. This would
permit the use of a single set calibration data to be used across all machines and the
IPV0 and IPV values scaled according to the ratio of IPV0 and the expected reading
for zero depth.
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Figure 3.14 Removal of variation using a fixed scaling factor.
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4. Clinical Implications of Phantom Corrections
Chapter 3 has shown that the calculated electron density of materials imaged in a
clinically calibrated CT scanner does not always reflect the true value, and measuring
REDeff from an MV photon beam using the technique developed in this project has
revealed the limitations of CT based density calculations.. While the difference in CT
Number or RED may seem significant, the actual impact to patient plans requires
further planning studies to be performed. This involves performing treatment
calculations on both raw and corrected CT data and comparing the dose distribution
between the two, as well as practical verification on a linear accelerator using ion
chamber dosimetry. Depending upon the patient geometry and beam arrangements,
even a dramatic difference in CT Number may actually result in negligible change to
the planned dose. Natural variation in RED can occur throughout a uniform material
due to statistical noise, artefacts, the CT parameters such as tube voltage and field-ofview size, as well as the size of the object of interest (Inness et al, 2014). The IAEA
TRS430 report recommends consistency of RED to be within 0.02 of a baseline value
to ensure accurate dose determination. This chapter will aim to quantify the range of
dose variation that can be expected when this tolerance is exceeded, in order to
ascertain the true importance of using the correct density values in dose calculation.

4.1 Evaluation of the CIRS Thorax Phantom

The first study performed was to use an anthropomorphic thorax phantom
manufactured by CIRS. This phantom, featuring lungs and spinal column in a water
equivalent body, was imaged with the CT scanner and the average CT Number for
each tissue type converted to RED using the established clinical calibration. The CT
was operated under a regular clinical preset using 120kVp and 2mm slice thickness.
The images were exported to ImageJ for analysis using the largest region of interest
possible for each tissue type. For the lung, a large oval (2748 pixels) was used, a
circle of 486 pixels for the bone and an oval of 2049 pixels in the mediastinum region
for the body. For each slice, the ROI mean was recorded and the average and standard
deviation of these values calculated for the range of suitable slices.
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The phantom was then imaged on the EPID to establish the REDeff in the MV beam.
Conveniently, the phantom could be orientated so that the beam passed axially
through each part of the phantom separately with a perpendicular angle of incidence.
As the phantom separates into 1 cm slices, this allowed a choice in the thickness to be
imaged. Based upon the results discussed in section 3.3.2, it was decided to use a 5
cm thickness.
The RED as determined by the CT and EPID was then compared to that reported in
the manufacturer’s user manual. The results show that in the case of this product, the
density determined by the CT is within the confidence range of that measured in the
MV beam.

Table 4.1 RED for thorax phantom as computed from kV and MV imaging.
Structure

Reported

CT (kV)

EPID (MV)

Lung

0.207

0.183 ± 0.002

0.20 ± 0.02

Body

(1)

1.006 ± 0.003

1.01 ± 0.03

Spine

1.506

1.487 ± 0.001

1.51 ± 0.04

As this phantom represents similarly in both the kV and MV photon beams, one
would not expect a significant difference in distribution between dose calculated on
the original CT image and one in which the density information has been changed to
that derived from EPID measurements.
To analyse the impact of making such corrections, the CT image data was imported
into the Eclipse (Varian Medical Systems, Palo Alto, USA) treatment planning system
and the body, lungs and spine contoured. Three simple plans were created to simulate
typical treatment geometries. These included a single 10 MV posterior field to the
spine (figure 4.1), a 6 MV four field box arrangement to the mediastinum (figure 4.2),
and a pair of 6 MV opposed tangent fields to the chest wall (figure 4.3).
The isocentre position is displayed as a yellow ring, which for the spine and
mediastinum plans was kept at the CT origin, shown as a green crosshair. For the
chest wall plan, the isocentre was moved to facilitate using an asymmetric zero-jaw
position as is usually employed in such plans. For each field, a central yellow line
shows the central axis of the beam, and peripheral yellow lines define the jaw
positions. As the plans were modelled on an accelerator that does not have movable
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jaws, these lines are fixed at the maximum field size and the actual extent of the beam
as defined by the MLCs is shown by the orange lines. The area blocked by MLCs is
also shown with green boxes. When the reference point marker is highlighted it
indicates that the displayed image plane is running through the reference point. When
the marker is less significant, the reference point lies outside the plane of the image.

Figure 4.1 Field geometry and reference point positions for the Spine plan.

Figure 4.2 Field geometry and reference point position for the Mediastinum plan.
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Figure 4.3 Field geometry and reference point position for the Chest Wall plan.

These plans were then duplicated onto a copy of the CT data set in which the body,
lungs and spine were given a CT Number override corresponding to the EPIDmeasured REDeff in table 4.1. For each plan, a total of 100 MU was distributed evenly
across the fields so that a dose in the order of 1Gy was planned for the volume of
interest and associated reference point. The reference point dose and maximum dose
was recorded for both the kV-based data (‘kV plan’) and MV-based data (‘MV plan’)
and the percentage difference in dose recorded upon correcting to the MV plan.
Additionally, the Plan Sum feature was used to display the dose difference between
the two plans throughout the full volume of the plan, by subtracting one dose
distribution from the other and leaving a display of the dose difference. Since the Plan
Sum can not display negative dose, this was performed both for kV-MV and MV-kV
to ensure all regions of hot- or cold-spots were located. As a delivered dose of around
1Gy was planned, an isodose level of 0.01Gy in these plans indicates a variation of
approximately 1 % between the kV and MV plans.

4.1.1

CIRS Thorax Phantom – Spine results

The two reference points in the Spine plan had a decrease in dose of 0.8 % once the
MV derived data was used. As MV data for all tissue types is a slightly higher
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electron density, this is anticipated as the points are simply at a marginally greater
effective depth. The difference maps are easily explained, with the kV-MV showing a
general 0.5-1 % higher dose downstream of the bone due to the lower bone density in
the case of the kV plan. The MV plan is hotter at the posterior edge of the bone,
where the denser bone will produce additional backscatter at the interface.

Table 4.2 Results for the Spine plan.
kV plan

MV plan

Dose to reference point ‘Spine A’

0.886

0.879

Percent
difference
-0.8

Dose to reference point ‘Spine B’

0.620

0.615

-0.8

Max dose in plan

1.387

1.388

0.1

Largest point difference (kV-MV)

0.018 Gy

Largest point difference (MV-kV)

0.016 Gy

Largest point difference as percent of reference dose A

2.1 %

Figure 4.4 Dose distribution for the Spine plan as calculated on the original kV CT data,
through the plane of the centre of the field.
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Figure 4.5 Dose distribution for the Spine plan as calculated on the overridden MV-based
data, through the plane of the centre of the field.

Figure 4.6 kV-MV dose difference for the Spine plan showing where the kV-based plan is
hotter, through the plane of maximum difference.
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Figure 4.7 MV-kV dose difference for the Spine plan showing where the MV-based plan is
hotter, through the plane of maximum difference.

4.1.2

CIRS Thorax Phantom – Mediastinum results

The dose volume in this configuration shows a negligible change of 0.2 % between
the plans. The only section of more than 0.5 % difference is in the right anterior
region, surrounding a portion of the surface and lung/body interface. The fact that this
is confined to boundaries and occurs unilaterally in an otherwise symmetric plan
suggests it is due only to inconsistency in how closely the manual contouring of the
structure follows the raw data.

Table 4.3 Results for the Mediastinum plan.
kV plan

MV plan

Dose to reference point ‘Mediastinum A’

0.994

0.992

Percent
difference
-0.2

Max dose in plan

1.064

1.065

0.1

Largest point difference (kV-MV)

0.028 Gy

Largest point difference (MV-kV)

0.014 Gy

Largest point difference as percent of reference dose

2.8 %
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Figure 4.8 Dose distribution for the Mediastinum plan as calculated on the original kV CT
data, through the plane of the centre of the field.

Figure 4.9 Dose distribution for the Mediastinum plan as calculated on the overridden MVbased data, through the plane of the centre of the field.
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Figure 4.10 kV-MV dose difference for the Mediastinum plan showing where the kVbased plan is hotter, through the plane of maximum difference.

Figure 4.11 MV-kV dose difference for the Mediastinum plan showing where the MVbased plan is hotter, through the plane of maximum difference.
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4.1.3

CIRS Thorax Phantom – Chest Wall results

The Chest Wall plan varied by only 0.3 % to the reference point, but 1.7 % in
maximum plan dose. In such geometries, with a thin section of tissue and opposing
fields, small hotspots can be very sensitive to change, but as evidenced by similarity
of the dose distribution in figures 4.12 and 4.13, this is not indicative of the general
variation between the plans. Similarly to the Mediastinum plan, the variation is
confined to the lung/body interface on the right hand side as shown in the Plan Sum
figures 4.13 and 4.14.

Table 4.4 Results for the Chest Wall plan.
kV plan

MV plan

Dose to reference point ‘Chest Wall A’

1.056

1.059

Percent
difference
0.3

Max dose in plan

1.122

1.103

-1.7

Largest point difference (kV-MV)

0.028 Gy

Largest point difference (MV-kV)

0.016 Gy

Largest point difference as percent of reference dose

2.7 %

Figure 4.12 Dose distribution for the Chest Wall plan as calculated on the original kV CT data,
through the plane of the centre of the field.
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Figure 4.13 Dose distribution for the Chest Wall plan as calculated on the overridden
MV-based data, through the plane of the centre of the field.

Figure 4.14 kV-MV dose difference for the Chest Wall plan showing where the kV-based
plan is hotter, through the plane of maximum difference.
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Figure 4.15 MV-kV dose difference for the Chest Wall plan showing where the MV-based
plan is hotter, through the plane of maximum difference.

The comparison of dose distributions across these three sites confirmed that the kVbased image data of this phantom provides suitable information for MV treatment
planning, with at most 0.8 % change in reference point dose. The largest overall
variation was 2.8 %, which as explained above is not representative of a change of
dose due to different CT Numbers but simply due to minor disparity in the geometry
of structures. Only in areas of relative homogeneity, as would be suitable for an ICRU
reference point (ICRU Report 50, 1993), can true comparisons of the dose difference
be performed.

4.2 Test of a Theoretical Phantom

As expected due to the similarity of the kV- and MV-derived information in table 4.1,
the phantom tested in section 4.1 shows little change when bulk conversions to MV
based electron densities are carried out. However, it has been shown that not all
materials perform as well, with some media showing significant inaccuracy in the
RED displayed by the CT (table 3.6). In this section, the tests of section 4.1 are
replicated for a theoretical phantom based on the geometry of the same thorax
phantom but with bulk density overrides to simulate having a phantom where the

68

Chapter4: Clinical Implications of Phantom Corrections

lung, body and bone are constructed of the previously tested Gammex lung, Perspex
and Gammex cortical bone respectively. Using the values from table 3.6, a series of
plans were calculated where the structures were assigned an RED based on the kVderived data, emulating a CT scan of the imaginary phantom. These plans were then
compared to those where the RED was assigned based on the MV data obtained from
EPID measurements. The values used are summarised in table 4.5.

Table 4.5 RED for theoretical phantom as computed from kV and MV imaging.
Structure

Assumed Material

CT (kV)

EPID (MV)

Lung

Gammex 455

0.21

0.28

Body

Perspex

1.07

1.18

Spine

Gammex 450

1.30

1.73

The results are also analysed by comparison of Dose Volume Histograms (DVH). The
DVH is a valuable tool for visualising the absorbed dose to structures in a plan, with a
graphic display of the dose versus structure volume, and an illustration of what
proportion of a structure that is receiving a specified dose. This is especially important
for organs such as the lungs, which are classed as ‘parallel’ organs. This means that
the most important factor is the amount of the organ that is irradiated beyond a certain
dose, and that a small volume of high dose is tolerated provided the majority of the
organ is below a certain level. In contrast, ‘serial’ structures such as the spinal cord
may suffer damaging effects if even a small volume receives a dose higher than the
tolerance limit (ICRU Report 62, 1999).

4.2.1

Theoretical Phantom – Spine results

In this case the effect of correcting to EPID-based densities was substantial. The RED
of the body and spine is underestimated in the CT data, meaning that less attenuation
is predicted by the planning system. The reference point doses are significantly less
when the MV data is used; a significant reduction in dose occurs behind the spine due
to significantly higher attenuation. Heightened dose in front of the bone is also
modelled due to the increase in backscatter as well as the increased energy deposition
in denser body tissue. As well as affecting the depth of penetration, the increased
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density of the bone can be seen to cause a noticeable change in the shape of the
isodose lines. The DVH shows that although the maximum doses to the body and
spine have very little change, there is an overall reduction in dose throughout each
structure that is of clinical significance. This magnitude of under-dosing to a targeted
treatment volume could result in failure to properly control the disease.

Table 4.6 Results for the Spine plan.
kV plan

MV plan

Dose to reference point ‘Spine A’

0.896

0.839

Percent
difference
-6.4

Dose to reference point ‘Spine B’

0.619

0.565

-8.7

Max dose in plan

1.393

1.400

0.5

Largest point difference (kV-MV)

0.061 Gy

Largest point difference (MV-kV)

0.032 Gy

Largest point difference as percent of reference dose A

6.8 %

If this theoretical phantom was used to conduct a physics dosimetry measurement,
there would be significant disagreement between the planned and measured dose that
would not be attributable to actual planning or delivery limitations.

Figure 4.16 Dose distribution for the Spine plan as calculated on the theoretical kV CT
data, through the plane of the centre of the field.
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Figure 4.17 Dose distribution for the Spine plan as calculated on the overridden MV-based
data, through the plane of the centre of the field.

Figure 4.18 kV-MV dose difference for the Chest Wall plan showing where the kV-based
plan is hotter, through the plane of maximum difference.
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Figure 4.19 MV-kV dose difference for the Chest Wall plan showing where the MV-based
plan is hotter, through the plane of maximum difference.

Figure 4.20 DVH for the Spine plans.
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4.2.2

Theoretical Phantom – Mediastinum results

In this four field plan, the change in dose distribution is less straightforward than for a
single field, yet there remains a significant variation in the dose coverage between the
kV and MV plans. The box representing the target volume drops by 3 % or more
across the entire volume, and again there are large variations to the DVH of the
contoured structures.

Table 4.7 Results for the Mediastinum plan.
kV plan

MV plan

Dose to reference point ‘Mediastinum A’

0.984

0.945

Percent
difference
-4.0

Max dose in plan

1.053

1.026

-2.6

Largest point difference (kV-MV)

0.047 Gy

Largest point difference (MV-kV)

0.003 Gy

Largest point difference as percent of reference dose

4.8 %

Figure 4.21 Dose distribution for the Mediastinum plan as calculated on the theoretical kV
CT data, through the plane of the centre of the field.
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Figure 4.22 Dose distribution for the Mediastinum plan as calculated on the overridden
MV-based data, through the plane of the centre of the field.

Figure 4.23 kV-MV dose difference for the Mediastinum plan showing where the kVbased plan is hotter, through the plane of maximum difference. An MV-kV dose difference
is not shown since the largest difference was negligible.
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Figure 4.24 DVH for the Mediastinum plans.

4.2.3

Theoretical Phantom – Chest Wall results

The MV plan in this case was cooler by up to 2.4 % in the target area. As this
irradiated volume is relatively small there is not a significant impact on the DVH,
however the difference in dose coverage is clearly evident in the isodose lines in
figures 4.25 and 4.26.

Table 4.8 Results for the Chest Wall plan.
kV plan

MV plan

Dose to reference point ‘Chest Wall A’

1.051

1.029

Percent
difference
-2.1

Max dose in plan

1.097

1.091

-0.5

Largest point difference (kV-MV)

0.025 Gy

Largest point difference (MV-kV)

0.016 Gy

Largest point difference as percent of reference dose

2.4 %
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Figure 4.25 Dose distribution for the Chest Wall plan as calculated on the theoretical kV
CT data, through the plane of the centre of the field.

Figure 4.26 Dose distribution for the Chest Wall plan as calculated on the overridden MVbased data, through the plane of the centre of the field.
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Figure 4.27 kV-MV dose difference for the Chest Wall plan showing where the kV-based
plan is hotter, through the plane of maximum difference.

Figure 4.28 MV-kV dose difference for the Chest Wall plan showing where the MV-based
plan is hotter, through the plane of maximum difference.

77

Chapter4: Clinical Implications of Phantom Corrections

Figure 4.29 DVH for the Chest Wall plans.

It can be seen from the results in this chapter that the errors induced by imaging
radiation therapy phantoms in a diagnostic beam quality can have significant impact.
If the correct density is not obtained and applied, the planned dose can vary from the
actual dose by more than 5 %. This level of discrepancy is unacceptable for effective
radiation therapy (ICRU Report 24, 1976). The technique developed in this project
allows these correct densities to be measured so that these corrections can be made.

4.3 Dose Point Verification Measurements
The planning studies in the preceding sections demonstrate the variation in dose
distribution that can be observed due to differences in assigned RED. To support the
use of the REDeff as determined using the presented technique, an end-to-end test was
designed to compare actual delivered dose to planning system calculations with and
without density corrections.
Perspex blocks were selected for this study, as these were available with a cavity for
regular output constancy checks with a PTW Farmer-type ionisation chamber. It is a
commonly used material and conveniently had different RED values calculated using
the CT scanner, the EPID and the nominal theoretical value. Recalling the results
shown in table 3.6, the RED for one of these blocks was shown as 1.074 in the CT
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image, but REDeff was determined to be 1.18 in the treatment beam. The blocks were
assembled on the CT couch as shown in figure 4.30, with a solid Perspex rod used to
fill the central ion chamber cavity for image acquisition. A clinical scan protocol was
used featuring 120 kV potential and variable tube current.

Figure 4.30 The Perspex blocks used for measurements

This scan was transferred to the Eclipse treatment planning system where two plans
were generated with a field size of 10.4 × 10.4 cm2, 6 MV photons, Gantry angle 0º,
100 cm SSD and 100 MU. The first plan used the raw CT data, and the second used a
bulk density override to the REDeff value of 1.18 (figure 4.31). A reference point was
generated in the plans at the location of the ion chamber, a depth of 10.7 cm on the
central axis. The calculated dose at this point was recorded for each plan (table 4.9).

The ion chamber used for the experiment was set up under reference calibration
conditions (10 cm depth, 90 cm SSD, on the central axis) in a water phantom. Using
the reference field size of 10.4 × 10.4 cm2, a 100 MU 6 MV beam was delivered and
the collected charge recorded. As the calibration under these conditions is known to
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be 1 cGy/1 MU, this allowed a relation between absorbed dose to water and collected
charge to be established. The chamber was then used in the Perspex as per the planned
arrangement to measure dose at the position of the reference point. Two
measurements were made under both circumstances, and in each case no variation
was observed.

Figure 4.31 The calculated dose distribution on the Perspex blocks using raw CT data (top)
and with bulk density corrections (bottom)
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Table 4.9 Results for the dose point verification.
Planned dose using raw data

0.794 Gy

Planned dose using corrected data

0.768 Gy

Charge collected under reference conditions

18.00 nC

Chamber calibration is therefore

18.00 nC/Gy

Charge collected in Perspex

13.82 nC

Dose measurement in Perspex therefore

0.768 Gy

It can be seen in table 4.9 that the measured dose agreed perfectly with the planned
dose based upon the EPID-derived corrections. In contrast, the dose calculated on the
raw CT data was 3.4 % high, owing to an underestimation of attenuation due to the
assignment of an RED that is lower than reality. Lastly, a third plan was calculated
using an assumed PMMA RED of 1.15. Using this value rather than the actual
measured REDeff of 1.18, the planned dose would still have been 0.9 % high.
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5. Implementation for Prosthesis Identification
The results shown in section 3.3 are based upon simple geometry, using absorbers that
are flat, much larger than the field size and consistent throughout the area of analysis.
This is very well for phantom studies, but the possibility of measuring a patient
prosthesis presents more complex circumstances as the implant is irregular in size and
shape.
A metallic hip prosthesis was acquired from the Princess Alexandra Hospital
orthopaedics division to simulate a true clinical scenario as closely as possible. The
sample was imprinted with 1⅜, the diameter of the ball in inches, and ALIVIUM, which
was found to be a cobalt-chromium-molybdenum alloy and registered trademark of
Zimmer Great Britain. The implant was suspended in a plastic container using tape,
and the container filled with water for the measurements.

Figure 5.1 The set up for prosthesis measurements.

A CT acquisition was made of the insert, which provided an excellent example of the
extent that high density materials degrade the image. The bounds of the prosthesis
were entirely undefined, and the CT Number of the surrounding water was severely
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affected. Prior to assignment of any densities, the borders of the implant and local
tissue types must be contoured using manipulation of window settings and
observation of unaffected slices to best estimate the true bounds of these structures.

Figure 5.2 Artefact seen in the CT image of the high density prosthesis.

While in the case of this experiment the dimensions of the insert can be measured
directly, the size of an implanted prosthesis would need to be established by other
means. This could be in the form of a 2D scanogram image on the CT, normally used
to localise the area in which to perform the tomographic image acquisition, or by
using onboard imaging on the treatment unit with either the EPID or kV imaging
system. In some cases, adjustment of the window and level settings to the top end of
the scale can provide adequate definition of the insert shape in a CT image.

Figure 5.3 Various options for determining the thickness of the insert, from left to right:
The scanogram image from a CT, an EPID image, a 2D planar kV image using the onboard
cone-beam CT imager.

A TomoTherapy machine was again utilised to acquire an MVCT image, which
showed a dramatic difference to the conventional CT scan. The structure of the
prosthesis was clearly presented and the surrounding water not affected by image
artefacts. As in section 3.3.3, the Gammex CTED calibration phantom was imaged at
the same time, however this time a titanium insert (RED = 3.79) was incorporated
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into the phantom. As the expected RED of the Co-Cr-Mo object is around 6.8
(estimated uncertainty 0.3 based on variation between alloys), an extrapolation is still
required in order to determine RED from the MVCT. Using a linear extrapolation
based on the two highest density calibration points, the RED of the implant was
estimated to be around 7.1.

Figure 5.4 Two slices of the MVCT acquisition from the TomoTherapy machine.

The first step in utilising the EPID to measure the REDeff was to obtain the IPV0
value. The average of five images was used for the measurements in this experiment.
In order to maximise accuracy, this was done with the empty plastic container in the
beam but so that the metal insert was outside the beam. The impact of the container
base was therefore accounted for in the background measurement. Following this, the
container was filled with 10 cm ±0.1 cm of water as measured with a ruler. As a
second measure of the water depth, and as a verification of the reference data against
a true water phantom, measurements were taken through the water without the insert
in the beam. Based on the average of five images, the computed thickness of water
was 10.05 cm which agreed with the ruler measurement, however an uncertainty of
0.5 cm was encountered due to variance in the IPV0 measurements, and this is carried
on to subsequent calculations.
As these measurements were performed prior to the MVCT acquisition shown in
figure 5.4, the internal structure of the prosthetic was unknown. Based on the images
shown in figure 5.3, it was suspected that the ball section might be hollow, and this
was confirmed with attempted REDeff measurement through this part of the sample.
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The calculated REDeff was 2.4 ± 0.3, far less than the expected value assuming the
ball to be solid metal.
The insert was then aligned so that the beam passed through the blade rather than the
ball. To ensure the beam was not overshooting the blade, the treatment couch was
raised until the width of the field, naturally converging nearer the x-ray source, was
less than the width of the sample. The effective thickness of the sample was
determined to be 9mm – the thickest point was measured using a vernier caliper to be
10mm at maximum however the tapering sides mean that an overestimation of
attenuation would occur if this were to be used to represent the entire region of
analysis (a 20 × 20 pixel square). The water equivalent thickness through the entire
10 cm phantom was measured to be 14.9 ± 0.7 cm at this point and, accounting for the
9.1 cm of included water leaves a water equivalent thickness of 5.8 ± 0.7 cm for the
0.9 cm unknown medium which equates to a REDeff of 6.4 ± 0.7.
This range of confidence comfortably covers the expected result for a Co-Cr-Mo
alloy. Recalling the purpose of this tool as a way to distinguish between the materials
that are known to be used in orthopaedic inserts, the results indicate that at least from
a technical standpoint this technique is capable of classifying an implanted prosthesis
as either titanium or the higher density alloys steel and Co-Cr-Mo, from which point
established density values for these materials can be used to correct treatment plan
data according to the recommendations of the AAPM (Reft et al, 2003).
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6. Discussion
The results of this study demonstrate that an EPID can be used to identify an effective
RED of a material based on the pixel information in the acquired image and that this
value, which takes into account the effects of the imaged material on the megavoltage
treatment beam, does not necessarily equate to RED as it is conventionally acquired
from kilovoltage X-ray CT images.
The technique outlined in this work was designed to fulfil two applications; to
characterise the properties of phantom and bolus materials and to identify the
composition of an implanted prosthesis.
The need for an accurate representation of phantom electron density was
demonstrated in chapter 4, in which it was shown that relying upon kV-derived
density information for a phantom optimised for MV accuracy can lead to significant
differences in dose calculation. If dose calculations are performed on an uncorrected
phantom to assist with patient planning, the error may propagate directly into the
patient treatment plan. Where dose calculations are performed on the phantom and
compared to phantom measurements as part of a patient-specific measurement, the
level of agreement between the measured and calculated doses will not be a true
reflection of the plan accuracy. A true delivery error could be masked by an opposing
systemic difference between the delivered and planned dose, or conversely an
accurate and effective patient plan could be abandoned if it returns a false negative
during quality assurance. The ion chamber dosimetry performed in section 4.3 proves
that failure to assign MV-derived density overrides can have clinically significant
effects in even the simplest of cases.

The proposed method of measuring relative electron density of a phantom was found
to be accurate and can be used to evaluate water equivalent materials with high
precision. Plastic Water, previously commissioned for clinical use, was used to
acquire the calibration data and therefore the accuracy of the results is dependent
upon the use of 0.995 as the RED for this material. Alternatively, true water could be
used to acquire calibration data, however this would be extremely cumbersome and
time consuming and the uncertainty in measuring the water depth would make this
impractical.
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The REDeff measurement method, as described herein, utilizes only a small region of
interest in the centre of the EPID image and is therefore limited to the evaluation of
materials positioned on the central axis of the linac beam. This simplification means
that the method can be adopted for immediate use, without the need for any
modifications to the EPID panel or the development of any in-house analysis
software. One possible avenue for extending this project therefore involves the
extension of the analysis to include all pixels in the EPID image, to allow the
evaluation of two-dimensional REDeff maps for complex or heterogeneous phantoms.
In order to develop the concept for measurement of a prosthetic implant, the method
was first verified using simple two-part slab phantoms. All measurements agreed with
the expected RED within the defined uncertainty, however when applying the
technique to this type of measurement the level of certainty possible in measuring a
homogeneous phantom could not be achieved. This is primarily due to the smaller
thickness of the unknown sample and inability to divide the uncertainty in pixel value
across a larger sample as is possible when imaging a homogeneous phantom. The
larger thickness of the overall phantom also contributes to the larger uncertainty in the
conversion of IPVatt to water equivalent thickness as detailed in section 3.3.2. The
two-part phantoms were kept to dimensions that were more representative of a clinical
scenario.
The use of a submerged metallic hip implant tested the accuracy of the system under
realistic conditions. Despite the complex shape of the prosthesis, the REDeff was able
to be successfully determined by the EPID with the level of uncertainty falling in the
second significant figure of the result. This level of accuracy is adequate to categorise
the implant as either titanium or a dense alloy, so in an experimental setting the
process can be deemed a success.
In order to be implemented clinically, it would be desirable to extend the method to
operate with wide beam geometry rather than limiting to a narrow field size. Firstly,
the use of a wide beam would potentially allow for implant identification based on
analysis of an existing treatment field, allowing retrospective verification of the
densities used in the TPS and adaption of plans where necessary. Removing the need
for a dedicated measurement field would eliminate additional patient dose as well as
extra treatment time, thus also addressing what would be the grounds of protest to the
use of the measurement tool. Another limitation of the current technique is that in
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order to accurately target the prosthesis and ensure the field is not overshooting the
insert, the patient would need to be positioned at a very short SSD so that the field
area is small enough to be confined to the desired location.
The reason for these requirements is for the definition of IPV to hold, as if the
equivalent thickness varies significantly within the beam area, the assignment of the
pixel scaling factor becomes unpredictable. The combination of the pixel value in the
region of interest with a PSF that may be influenced by a different region of the image
area would not give a meaningful IPV that can be related to the calibration data.
Evolving this technique to be compatible with wide beams of varying equivalent path
length would likely require bypassing the use of the PSF altogether, with a method of
extracting raw pixel information from a clinical scan needed. This is achievable in the
service mode of the iView GT software, but applying this to a patient image acquired
in clinical mode would require further investigation.
If a solution to this technical impediment were found allowing calculation based on
treatment fields, further development of the procedure would require a number of
steps. Firstly, the field size response would need to be accounted for either by the use
of field size scaling factors applied to the calibration data, or the collection of
calibration data at a number of field sizes and interpolation between the nearest
values. The most plausible way of classifying the field size of an irregularly shaped
treatment field would be using the equivalent square area, 4 × area ÷ perimeter,
which is commonly used in dose calculation to find the square field that would give
similar scatter characteristics to the field in question.
The use of treatment fields at gantry angles other than 0° would require revisiting the
practicalities of calibration data acquisition and measurement of IPV0, as the presence
of the treatment couch in the path of the beam will not be consistent.
Even accounting for these factors, the use of a wide field to measure the density of a
relatively small prosthesis could nevertheless be inaccurate using the described water
equivalence method, as correcting for the effect of field size would still assume
consistent scatter conditions throughout the field. When the media to each side of the
subject is of different electron density, the scatter contribution to the measured result
will differ from that of the homogeneous Plastic Water calibration measurements.
Figure 3.5 showed the effect of changing scatter conditions by reducing field size; it is
possible that when considering materials where the density varies by a factor of
around 7, such as a steel implant in soft tissue, that the difference in pixel response
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could approach that seen when changing field size. Whether the required accuracy of
the technique could be maintained in these conditions is unknown.
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7. Conclusion
This work demonstrates an effective way of determining the electron density
properties of an unknown material to improve the accuracy of radiotherapy planning
calculations. Due to current limitations, it is most useful for commissioning new
phantoms and bolus materials. Further development of this approach could see the
technique used to identify unknown prosthetic materials in radiotherapy patients,
which would require the method to be adapted for use with clinical treatment fields
and angles.
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